[
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:646",
    "phenodigmScore": 44.23,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy,HP:0004333 Bone-marrow foam cells,HP:0001744 Splenomegaly,HP:0006913 Frontal cortical atrophy,HP:0001433 Hepatosplenomegaly,HP:0002059 Cerebral atrophy,HP:0002079 Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 8.47,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0001501 abnormal sleep pattern,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Niemann-Pick Disease Type C",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:105650",
    "phenodigmScore": 52.18,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0030270 Elevated red cell adenosine deaminase level,HP:0001875 Neutropenia,HP:0010446 Tricuspid stenosis,HP:0004810 Congenital hypoplastic anemia,HP:0001635 Congestive heart failure,HP:0001896 Reticulocytopenia,HP:0001873 Thrombocytopenia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 18.73,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 85.63,
    "markerNumModels": 9,
    "diseaseTerm": "Diamond-Blackfan Anemia 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:824",
    "phenodigmScore": 59.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0004447 Poikilocytosis,HP:0001978 Extramedullary hematopoiesis,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0001409 Portal hypertension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 23.5,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 95.53,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Myelofibrosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:207731",
    "phenodigmScore": 58.4,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 28.08,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 88.72,
    "markerNumModels": 9,
    "diseaseTerm": "Aplasia Cutis Congenita With Intestinal Lymphangiectasia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617201",
    "phenodigmScore": 67.58500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0032388 Periventricular nodular heterotopia,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0002539 Cortical dysplasia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 35.17,
    "diseaseModelAvgRaw": 0.68,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Nodular Heterotopia 7",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:85443",
    "phenodigmScore": 46.795,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001639 Hypertrophic cardiomyopathy,HP:0031595 Abnormal P wave,HP:0002239 Gastrointestinal hemorrhage,HP:0008652 Autonomic erectile dysfunction,HP:0005307 Postural hypotension with compensatory tachycardia,HP:0003115 Abnormal EKG,HP:0030164 Jaw claudication,HP:0011675 Arrhythmia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.86,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 79.73,
    "markerNumModels": 9,
    "diseaseTerm": "Al Amyloidosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:89842",
    "phenodigmScore": 44.845,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031831 Decreased serum zinc,HP:0040303 Decreased serum iron,HP:0031903 Abnormal circulating selenium concentration,HP:0003073 Hypoalbuminemia,HP:0003234 Decreased plasma carnitine",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.87,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 78.82,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Recessive Generalized Dystrophic Epidermolysis Bullosa, Intermediate Form",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:139578",
    "phenodigmScore": 55.03,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003431 Decreased motor nerve conduction velocity,HP:0002143 Abnormality of the spinal cord,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.57,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 90.49,
    "markerNumModels": 9,
    "diseaseTerm": "Mutilating Hereditary Sensory Neuropathy With Spastic Paraplegia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:86839",
    "phenodigmScore": 52.605,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010876 Abnormal circulating protein concentration,HP:0012116 Abnormal circulating albumin concentration,HP:0000573 Retinal hemorrhage",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 21.27,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.6,
    "diseaseModelMaxNorm": 83.94,
    "markerNumModels": 9,
    "diseaseTerm": "Refractory Anemia With Excess Blasts",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618929",
    "phenodigmScore": 47.075,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0005180 Tricuspid regurgitation,HP:0001274 Agenesis of corpus callosum,HP:0033105 Interhypothalamic Adhesion,HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.85,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 76.3,
    "markerNumModels": 9,
    "diseaseTerm": "Agenesis Of Corpus Callosum, Cardiac, Ocular, And Genital Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618733",
    "phenodigmScore": 46.5,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000762 Decreased nerve conduction velocity,HP:0007165 Periventricular heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0007078 Decreased amplitude of sensory action potentials",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.48,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 71.52,
    "markerNumModels": 9,
    "diseaseTerm": "Neuromuscular Oculoauditory Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:255138",
    "phenodigmScore": 55.53,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007109 Periventricular cysts,HP:0007165 Periventricular heterotopia,HP:0007016 Corticospinal tract hypoplasia,HP:0001302 Pachygyria,HP:0200012 Short corpus callosum,HP:0006970 Periventricular leukomalacia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 36.07,
    "diseaseModelAvgRaw": 0.74,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 74.99,
    "markerNumModels": 9,
    "diseaseTerm": "Pyruvate Dehydrogenase E1-Beta Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619101",
    "phenodigmScore": 66.6,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 40.38,
    "diseaseModelAvgRaw": 0.83,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 92.82,
    "markerNumModels": 9,
    "diseaseTerm": "Mismatch Repair Cancer Syndrome 4",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:310440",
    "phenodigmScore": 47.72,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0001371 Flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 17.93,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myopathy, X-Linked, With Excessive Autophagy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:600072",
    "phenodigmScore": 44.18,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.62,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 79.74,
    "markerNumModels": 9,
    "diseaseTerm": "Fatal Familial Insomnia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:329228",
    "phenodigmScore": 69.245,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002472 Small cerebral cortex,HP:0002538 Abnormal cerebral cortex morphology,HP:0012757 Abnormal neuron morphology,HP:0002060 Abnormal cerebral morphology,HP:0009879 Simplified gyral pattern,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 46.53,
    "diseaseModelAvgRaw": 0.88,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 91.96,
    "markerNumModels": 9,
    "diseaseTerm": "Microcephalic Primordial Dwarfism Due To Znf335 Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:300570",
    "phenodigmScore": 54.475,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001338 Partial agenesis of the corpus callosum,HP:0025101 Dysgenesis of the hippocampus,HP:0040326 Hypoplasia of the olfactory bulb,HP:0007048 Large basal ganglia,HP:0000609 Optic nerve hypoplasia,HP:0009879 Simplified gyral pattern,HP:0011451 Primary microcephaly,HP:0001339 Lissencephaly,HP:0030302 Agenesis of the anterior commissure,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0012697 Small basal ganglia,HP:0010663 Abnormality of thalamus morphology,HP:0002134 Abnormality of the basal ganglia,HP:0006956 Dilation of lateral ventricles,HP:0007260 Type II lissencephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 24.64,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 84.31,
    "markerNumModels": 9,
    "diseaseTerm": "Cortical Dysgenesis With Pontocerebellar Hypoplasia Due To Tubb3 Mutation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98889",
    "phenodigmScore": 43.394999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001349 Facial diplegia,HP:0032407 Bilateral perisylvian polymicrogyria,HP:0020190 Perisylvian predominant thick cortex pachygyria,HP:0011755 Ectopic posterior pituitary,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.38,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 71.41,
    "markerNumModels": 9,
    "diseaseTerm": "Bilateral Perisylvian Polymicrogyria",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:611603",
    "phenodigmScore": 70.955,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001339 Lissencephaly,HP:0001302 Pachygyria,HP:0002126 Polymicrogyria,HP:0031882 Agyria,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 48.21,
    "diseaseModelAvgRaw": 0.96,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 93.7,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:300624",
    "phenodigmScore": 44.245,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.39,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 81.1,
    "markerNumModels": 9,
    "diseaseTerm": "Fragile X Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618805",
    "phenodigmScore": 51.545,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 14.81,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 88.28,
    "markerNumModels": 9,
    "diseaseTerm": "Triokinase And Fmn Cyclase Deficiency Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3206",
    "phenodigmScore": 37.87,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.44,
    "diseaseModelAvgRaw": 0.09,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 71.3,
    "markerNumModels": 9,
    "diseaseTerm": "St√ºve-Wiedemann Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:64753",
    "phenodigmScore": 54.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002174 Postural tremor,HP:0003236 Elevated circulating creatine kinase concentration,HP:0003124 Hypercholesterolemia,HP:0006254 Elevated alpha-fetoprotein,HP:0003073 Hypoalbuminemia,HP:0002346 Head tremor",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 28.87,
    "diseaseModelAvgRaw": 0.64,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001513 limb grasping,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 80.16,
    "markerNumModels": 9,
    "diseaseTerm": "Spinocerebellar Ataxia With Axonal Neuropathy Type 2",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:224000",
    "phenodigmScore": 53.94500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.6,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Dysautonomia-Like Disorder",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100081",
    "phenodigmScore": 49.440000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0007380 Facial telangiectasia,HP:0001962 Palpitations,HP:0005180 Tricuspid regurgitation,HP:0002249 Melena,HP:0002615 Hypotension,HP:0002573 Hematochezia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.4,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.48,
    "markerNumModels": 9,
    "diseaseTerm": "Neuroendocrine Tumor Of The Rectum",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:601390",
    "phenodigmScore": 45.525000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032409 Subcortical band heterotopia,HP:0032388 Periventricular nodular heterotopia,HP:0009879 Simplified gyral pattern,HP:0001302 Pachygyria,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.62,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 76.43,
    "markerNumModels": 9,
    "diseaseTerm": "Van Maldergem Syndrome 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617563",
    "phenodigmScore": 40.69,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.83,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 73.55,
    "markerNumModels": 9,
    "diseaseTerm": "Orofaciodigital Syndrome Xvi",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "DECIPHER:29",
    "phenodigmScore": 57.370000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003431 Decreased motor nerve conduction velocity,HP:0002450 Abnormal motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 24.71,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.34,
    "diseaseModelMaxNorm": 90.03,
    "markerNumModels": 9,
    "diseaseTerm": "Charcot-Marie-Tooth syndrome type 1A (CMT1A)",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:171",
    "phenodigmScore": 41.21,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 5.03,
    "diseaseModelAvgRaw": 0.12,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 77.39,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Sclerosing Cholangitis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:556037",
    "phenodigmScore": 51.855000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.09,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.62,
    "markerNumModels": 9,
    "diseaseTerm": "Late-Onset Familial Hypoaldosteronism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:613658",
    "phenodigmScore": 41.25,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008282 Unconjugated hyperbilirubinemia,HP:0002901 Hypocalcemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 6.34,
    "diseaseModelAvgRaw": 0.15,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 76.16,
    "markerNumModels": 9,
    "diseaseTerm": "Rajab Interstitial Lung Disease With Brain Calcifications 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:228308",
    "phenodigmScore": 49.41,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002514 Cerebral calcification,HP:0001638 Cardiomyopathy,HP:0012722 Heart block,HP:0001302 Pachygyria,HP:0002126 Polymicrogyria,HP:0002134 Abnormality of the basal ganglia,HP:0011675 Arrhythmia,HP:0001274 Agenesis of corpus callosum,HP:0007229 Intracerebral periventricular calcifications",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.5,
    "diseaseModelAvgRaw": 0.52,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 75.32,
    "markerNumModels": 9,
    "diseaseTerm": "Carnitine Palmitoyl Transferase Ii Deficiency, Neonatal Form",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:64743",
    "phenodigmScore": 46.964999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002904 Hyperbilirubinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.35,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.58,
    "markerNumModels": 9,
    "diseaseTerm": "Hepatoportal Sclerosis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:168593",
    "phenodigmScore": 47.97,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001695 Cardiac arrest,HP:0011675 Arrhythmia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.82,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 81.12,
    "markerNumModels": 9,
    "diseaseTerm": "Sudden Infant Death-Dysgenesis Of The Testes Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:300957",
    "phenodigmScore": 49.945,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly,HP:0002500 Abnormal cerebral white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.38,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 83.51,
    "markerNumModels": 9,
    "diseaseTerm": "Intellectual Developmental Disorder, X-Linked 12",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:604715",
    "phenodigmScore": 54.355,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012173 Orthostatic tachycardia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.72,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.35,
    "diseaseModelMaxNorm": 91.99,
    "markerNumModels": 9,
    "diseaseTerm": "Orthostatic Intolerance",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:609049",
    "phenodigmScore": 48.019999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 16.24,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 79.8,
    "markerNumModels": 9,
    "diseaseTerm": "Pierson Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:610443",
    "phenodigmScore": 42.155,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly,HP:0001642 Pulmonic stenosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.89,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 76.42,
    "markerNumModels": 9,
    "diseaseTerm": "Koolen-De Vries Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:282166",
    "phenodigmScore": 50.67,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010542 Vestibular nystagmus,HP:0012332 Abnormal autonomic nervous system physiology,HP:0007183 Focal T2 hyperintense basal ganglia lesion,HP:0006943 Diffuse spongiform leukoencephalopathy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.43,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 87.91,
    "markerNumModels": 9,
    "diseaseTerm": "Inherited Creutzfeldt-Jakob Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99027",
    "phenodigmScore": 49.005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006958 Abnormal auditory evoked potentials,HP:0007377 Abnormality of somatosensory evoked potentials,HP:0001278 Orthostatic hypotension,HP:0007369 Atrophy/Degeneration affecting the cerebrum,HP:0006827 Atrophy of the spinal cord,HP:0005341 Autonomic bladder dysfunction,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0030890 Hyperintensity of cerebral white matter on MRI,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.36,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.65,
    "markerNumModels": 9,
    "diseaseTerm": "Adult-Onset Autosomal Dominant Leukodystrophy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615244",
    "phenodigmScore": 53.540000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 21.82,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.26,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 8",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:44",
    "phenodigmScore": 46.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000648 Optic atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.8,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 83.7,
    "markerNumModels": 9,
    "diseaseTerm": "Neonatal Adrenoleukodystrophy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:248200",
    "phenodigmScore": 65.505,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008035 Retinitis pigmentosa inversa,HP:0011504 Bull's eye maculopathy,HP:0000608 Macular degeneration",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 49.45,
    "diseaseModelAvgRaw": 1.05,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 1.94,
    "diseaseModelMaxNorm": 81.56,
    "markerNumModels": 9,
    "diseaseTerm": "Stargardt Disease 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:174000",
    "phenodigmScore": 49.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0002615 Hypotension,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.16,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.87,
    "markerNumModels": 9,
    "diseaseTerm": "Tubulointerstitial Kidney Disease, Autosomal Dominant, 2",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:102",
    "phenodigmScore": 52.62,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0012670 Orthostatic syncope,HP:0030880 Raynaud phenomenon,HP:0005341 Autonomic bladder dysfunction,HP:0008652 Autonomic erectile dysfunction,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.78,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 82.46,
    "markerNumModels": 9,
    "diseaseTerm": "Multiple System Atrophy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:150500",
    "phenodigmScore": 56.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000541 Retinal detachment,HP:0007992 Lattice retinal degeneration",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 39.24,
    "diseaseModelAvgRaw": 0.98,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.01,
    "diseaseModelMaxNorm": 74.26,
    "markerNumModels": 9,
    "diseaseTerm": "Lattice Degeneration Of Retina Leading To Retinal Detachment",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:370959",
    "phenodigmScore": 51.965,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0007204 Diffuse white matter abnormalities,HP:0000609 Optic nerve hypoplasia,HP:0001638 Cardiomyopathy,HP:0012695 Decreased thalamic volume,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0007260 Type II lissencephaly,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.2,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 80.73,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Muscular Dystrophy With Cerebellar Involvement",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:137280",
    "phenodigmScore": 63.64,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 36.16,
    "diseaseModelAvgRaw": 1.02,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Gastritis, Familial Giant Hypertrophic",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608097",
    "phenodigmScore": 68.11,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007165 Periventricular heterotopia,HP:0032388 Periventricular nodular heterotopia,HP:0000253 Progressive microcephaly,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 36.22,
    "diseaseModelAvgRaw": 0.66,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Heterotopia With Microcephaly, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2135",
    "phenodigmScore": 49.96,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0100585 Telangiectasia of the skin,HP:0011675 Arrhythmia,HP:0000252 Microcephaly,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.81,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 88.11,
    "markerNumModels": 9,
    "diseaseTerm": "Hennekam-Beemer Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:137200",
    "phenodigmScore": 45.74,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 13.97,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Neuromyotonia And Axonal Neuropathy, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608836",
    "phenodigmScore": 49.15,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0002269 Abnormality of neuronal migration,HP:0007023 Antenatal intracerebral hemorrhage,HP:0000252 Microcephaly,HP:0006799 Basal ganglia cysts,HP:0002126 Polymicrogyria,HP:0011675 Arrhythmia,HP:0001274 Agenesis of corpus callosum,HP:0007229 Intracerebral periventricular calcifications",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.69,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 80.61,
    "markerNumModels": 9,
    "diseaseTerm": "Carnitine Palmitoyltransferase Ii Deficiency, Lethal Neonatal",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:292",
    "phenodigmScore": 48.16,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0001638 Cardiomyopathy,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.13,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.19,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Enterovirus Infection",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616050",
    "phenodigmScore": 52.105000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003281 Increased circulating ferritin concentration,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.65,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 88.56,
    "markerNumModels": 9,
    "diseaseTerm": "Autoinflammation With Infantile Enterocolitis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:250972",
    "phenodigmScore": 59.165,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006989 Dysplastic corpus callosum,HP:0030048 Colpocephaly,HP:0000609 Optic nerve hypoplasia,HP:0002126 Polymicrogyria,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 46.5,
    "diseaseModelAvgRaw": 1.03,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 71.83,
    "markerNumModels": 9,
    "diseaseTerm": "Polymicrogyria With Optic Nerve Hypoplasia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:609039",
    "phenodigmScore": 46.415,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 12.84,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001501 abnormal sleep pattern",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Narcolepsy 3",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:441",
    "phenodigmScore": 49.935,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0001279 Syncope,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.42,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.45,
    "markerNumModels": 9,
    "diseaseTerm": "Pure Autonomic Failure",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:75376",
    "phenodigmScore": 59.730000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030632 Hypoautofluorescent macular lesion,HP:0007401 Macular atrophy,HP:0007703 Abnormality of retinal pigmentation,HP:0030499 Macular drusen,HP:0007793 Granular macular appearance,HP:0011509 Macular hyperpigmentation,HP:0012231 Exudative retinal detachment,HP:0011506 Choroidal neovascularization,HP:0007754 Macular dystrophy,HP:0007950 Peripapillary chorioretinal atrophy,HP:0030631 Hyperautofluorescent macular lesion,HP:0025574 Macular hemorrhage,HP:0030500 Yellow/white lesions of the macula,HP:0031526 Subretinal fluid,HP:0007937 Reticular pigmentary degeneration,HP:0030629 Perifoveal ring of hyperautofluorescence",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 54.1,
    "diseaseModelAvgRaw": 1.11,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 1.94,
    "diseaseModelMaxNorm": 65.36,
    "markerNumModels": 9,
    "diseaseTerm": "Familial Drusen",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2298",
    "phenodigmScore": 43.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003119 Abnormal circulating lipid concentration,HP:0004359 Abnormal circulating fatty-acid concentration,HP:0012153 Hypotriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.45,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.05,
    "markerNumModels": 9,
    "diseaseTerm": "Insulin-Resistance Syndrome Type B",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100080",
    "phenodigmScore": 49.715,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0007380 Facial telangiectasia,HP:0001962 Palpitations,HP:0005180 Tricuspid regurgitation,HP:0002249 Melena,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.95,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.48,
    "markerNumModels": 9,
    "diseaseTerm": "Neuroendocrine Tumor Of The Colon",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:97287",
    "phenodigmScore": 52.03,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0007380 Facial telangiectasia,HP:0001962 Palpitations,HP:0005180 Tricuspid regurgitation,HP:0030149 Cardiogenic shock,HP:0000845 Elevated circulating growth hormone concentration,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.2,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.86,
    "markerNumModels": 9,
    "diseaseTerm": "Bronchial Neuroendocrine Tumor",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619013",
    "phenodigmScore": 50.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 13.5,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 88.28,
    "markerNumModels": 9,
    "diseaseTerm": "Rajab Interstitial Lung Disease With Brain Calcifications 2",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:93274",
    "phenodigmScore": 45.15,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 5.03,
    "diseaseModelAvgRaw": 0.11,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 85.27,
    "markerNumModels": 9,
    "diseaseTerm": "Thanatophoric Dysplasia Type 2",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:108500",
    "phenodigmScore": 43.365,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 9.9,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 76.83,
    "markerNumModels": 9,
    "diseaseTerm": "Episodic Ataxia, Type 2",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100050",
    "phenodigmScore": 44.205,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.18,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.23,
    "markerNumModels": 9,
    "diseaseTerm": "Hereditary Angioedema Type 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:603671",
    "phenodigmScore": 52.13,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032388 Periventricular nodular heterotopia,HP:0040075 Hypopituitarism,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.26,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 83.0,
    "markerNumModels": 9,
    "diseaseTerm": "Acromelic Frontonasal Dysostosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618349",
    "phenodigmScore": 54.67,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 17.8,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Galloway-Mowat Syndrome 8",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99735",
    "phenodigmScore": 45.285000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0001376 Limitation of joint mobility",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 13.06,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonia Permanens",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:606353",
    "phenodigmScore": 54.11,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002127 Abnormal upper motor neuron morphology,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 24.46,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 83.76,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Lateral Sclerosis, Juvenile",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618480",
    "phenodigmScore": 50.485,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.89,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 92.08,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder With Seizures And Speech And Walking Impairment",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:43393",
    "phenodigmScore": 43.145,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.45,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 69.84,
    "markerNumModels": 9,
    "diseaseTerm": "Lambert-Eaton Myasthenic Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:152800",
    "phenodigmScore": 57.0,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008360 Neonatal hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 22.64,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.63,
    "diseaseModelMaxNorm": 91.36,
    "markerNumModels": 9,
    "diseaseTerm": "Lymphangiectasia, Intestinal",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:606070",
    "phenodigmScore": 46.685,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000762 Decreased nerve conduction velocity,HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.54,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 71.83,
    "markerNumModels": 9,
    "diseaseTerm": "Amyotrophic Lateral Sclerosis 21",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:611890",
    "phenodigmScore": 54.22,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001349 Facial diplegia,HP:0006802 Abnormal anterior horn cell morphology,HP:0007277 Paucity of anterior horn motor neurons,HP:0002059 Cerebral atrophy,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.45,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 89.99,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Arthrogryposis With Anterior Horn Cell Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90362",
    "phenodigmScore": 51.845,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002917 Hypomagnesemia,HP:0003075 Hypoproteinemia,HP:0002901 Hypocalcemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 14.97,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 88.72,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Intestinal Lymphangiectasia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:466650",
    "phenodigmScore": 43.715,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0005135 Abnormal T-wave,HP:0001657 Prolonged QT interval,HP:0012250 ST segment depression,HP:0030850 Abnormal pulse pressure,HP:0002615 Hypotension,HP:0011703 Sinus tachycardia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.79,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 77.64,
    "markerNumModels": 9,
    "diseaseTerm": "Exercise-Induced Malignant Hyperthermia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79500",
    "phenodigmScore": 45.37,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0002139 Arrhinencephaly,HP:0002126 Polymicrogyria,HP:0003298 Spina bifida occulta,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 6.44,
    "diseaseModelAvgRaw": 0.14,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0009937 abnormal neuron differentiation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 84.3,
    "markerNumModels": 9,
    "diseaseTerm": "Doors Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618795",
    "phenodigmScore": 58.39,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 16.78,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Juvenile Arthritis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:293978",
    "phenodigmScore": 48.815,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000824 Decreased response to growth hormone stimulation test,HP:0002615 Hypotension,HP:0012504 Abnormal size of pituitary gland",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.31,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.32,
    "markerNumModels": 9,
    "diseaseTerm": "Deficiency In Anterior Pituitary Function-Variable Immunodeficiency Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608104",
    "phenodigmScore": 50.32,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 9.1,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Ih",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2905",
    "phenodigmScore": 53.33,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001901 Polycythemia,HP:0001894 Thrombocytosis,HP:0002092 Pulmonary arterial hypertension,HP:0000870 Increased circulating prolactin concentration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 14.3,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 92.36,
    "markerNumModels": 9,
    "diseaseTerm": "Poems Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:367",
    "phenodigmScore": 46.29,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 9.0,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.58,
    "markerNumModels": 9,
    "diseaseTerm": "Glycogen Storage Disease Due To Glycogen Branching Enzyme Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619602",
    "phenodigmScore": 58.665000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0002126 Polymicrogyria,HP:0007363 Aplasia/Hypoplasia of the pyramidal tract,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 38.77,
    "diseaseModelAvgRaw": 0.85,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.09,
    "diseaseModelMaxNorm": 78.56,
    "markerNumModels": 9,
    "diseaseTerm": "Fetal Akinesia, Respiratory Insufficiency, Microcephaly, Polymicrogyria, And Dysmorphic Facies",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:598500",
    "phenodigmScore": 48.645,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.87,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 86.42,
    "markerNumModels": 9,
    "diseaseTerm": "Wolfram Syndrome, Mitochondrial Form",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:352582",
    "phenodigmScore": 46.445,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032388 Periventricular nodular heterotopia,HP:0006891 Thick cerebral cortex,HP:0025100 Abnormal hippocampus morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.48,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 71.41,
    "markerNumModels": 9,
    "diseaseTerm": "Familial Infantile Myoclonic Epilepsy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:203400",
    "phenodigmScore": 49.065000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.51,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.62,
    "markerNumModels": 9,
    "diseaseTerm": "Corticosterone Methyloxidase Type I Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:263570",
    "phenodigmScore": 58.795,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0002127 Abnormal upper motor neuron morphology,HP:0002500 Abnormal cerebral white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 43.0,
    "diseaseModelAvgRaw": 0.86,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 74.59,
    "markerNumModels": 9,
    "diseaseTerm": "Polyglucosan Body Neuropathy, Adult Form",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619055",
    "phenodigmScore": 45.16,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003236 Elevated circulating creatine kinase concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.63,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.69,
    "markerNumModels": 9,
    "diseaseTerm": "Mitochondrial Complex Iv Deficiency, Nuclear Type 12",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:85447",
    "phenodigmScore": 52.65,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001678 Atrioventricular block,HP:0011675 Arrhythmia,HP:0001638 Cardiomyopathy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.88,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 87.42,
    "markerNumModels": 9,
    "diseaseTerm": "Attrv30M Amyloidosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:178478",
    "phenodigmScore": 48.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001695 Cardiac arrest,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.38,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.12,
    "markerNumModels": 9,
    "diseaseTerm": "Infant Botulism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618572",
    "phenodigmScore": 64.74,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032388 Periventricular nodular heterotopia,HP:0000648 Optic atrophy,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.48,
    "diseaseModelAvgRaw": 0.56,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder With Cerebellar Hypoplasia And Spasticity",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615688",
    "phenodigmScore": 53.83,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0000822 Hypertension,HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0030880 Raynaud phenomenon,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0002633 Vasculitis,HP:0001888 Lymphopenia,HP:0001876 Pancytopenia,HP:0001409 Portal hypertension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 19.6,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 88.06,
    "markerNumModels": 9,
    "diseaseTerm": "Vasculitis, Autoinflammation, Immunodeficiency, And Hematologic Defects Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:305450",
    "phenodigmScore": 42.22,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001338 Partial agenesis of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.68,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 74.76,
    "markerNumModels": 9,
    "diseaseTerm": "Opitz-Kaveggia Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1084",
    "phenodigmScore": 64.825,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001302 Pachygyria,HP:0031882 Agyria",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.65,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Isolated Lissencephaly Type 1 Without Known Genetic Defects",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1304",
    "phenodigmScore": 49.58,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001701 Pericarditis,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001971 Hypersplenism,HP:0002326 Transient ischemic attack,HP:0012089 Arteritis,HP:0001873 Thrombocytopenia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.99,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 85.17,
    "markerNumModels": 9,
    "diseaseTerm": "Brucellosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614019",
    "phenodigmScore": 65.98,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000252 Microcephaly,HP:0001339 Lissencephaly,HP:0001274 Agenesis of corpus callosum,HP:0009879 Simplified gyral pattern",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 48.59,
    "diseaseModelAvgRaw": 0.91,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 83.37,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly 4",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:243910",
    "phenodigmScore": 39.06,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002436 Occipital meningocele",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.62,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0008503 abnormal spinal cord grey matter morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 70.5,
    "markerNumModels": 9,
    "diseaseTerm": "Arima Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1879",
    "phenodigmScore": 63.160000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0010739 Osteopoikilosis,HP:0003103 Abnormal cortical bone morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 51.78,
    "diseaseModelAvgRaw": 1.08,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 1.93,
    "diseaseModelMaxNorm": 74.54,
    "markerNumModels": 9,
    "diseaseTerm": "Melorheostosis With Osteopoikilosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615573",
    "phenodigmScore": 60.105000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 28.67,
    "diseaseModelAvgRaw": 0.67,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 9",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:610031",
    "phenodigmScore": 67.64,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006927 Unilateral polymicrogyria,HP:0001339 Lissencephaly,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly,HP:0006930 Frontoparietal cortical dysplasia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 51.91,
    "diseaseModelAvgRaw": 0.94,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 83.37,
    "markerNumModels": 9,
    "diseaseTerm": "Cortical Dysplasia, Complex, With Other Brain Malformations 7",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99828",
    "phenodigmScore": 51.83,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 12.54,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Dengue Fever",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:95613",
    "phenodigmScore": 52.91,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0000870 Increased circulating prolactin concentration,HP:0011748 Adrenocorticotropic hormone deficiency,HP:0008245 Pituitary hypothyroidism,HP:0002339 Abnormal caudate nucleus morphology,HP:0002893 Pituitary adenoma,HP:0040075 Hypopituitarism,HP:0000863 Central diabetes insipidus,HP:0000845 Elevated circulating growth hormone concentration,HP:0000824 Decreased response to growth hormone stimulation test,HP:0002615 Hypotension,HP:0008202 Reduced circulating prolactin concentration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.96,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.86,
    "markerNumModels": 9,
    "diseaseTerm": "Pituitary Apoplexy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:684",
    "phenodigmScore": 56.33,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0012903 Myotonia of the upper limb,HP:0012899 Handgrip myotonia,HP:0010548 Percussion myotonia,HP:0012904 Cold-sensitive myotonia,HP:0012900 Myotonia of the face,HP:0012901 Myotonia of the jaw,HP:0011809 Paradoxical myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 35.15,
    "diseaseModelAvgRaw": 0.79,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Paramyotonia Congenita Of Von Eulenburg",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617441",
    "phenodigmScore": 52.349999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 25.4,
    "diseaseModelAvgRaw": 0.66,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Thrombocytopenia, Anemia, And Myelofibrosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607432",
    "phenodigmScore": 72.3,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032409 Subcortical band heterotopia,HP:0001302 Pachygyria,HP:0031882 Agyria,HP:0002500 Abnormal cerebral white matter morphology,HP:0002282 Gray matter heterotopia,HP:0005484 Secondary microcephaly,HP:0001339 Lissencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 44.6,
    "diseaseModelAvgRaw": 0.86,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:610954",
    "phenodigmScore": 45.445,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.65,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.24,
    "markerNumModels": 9,
    "diseaseTerm": "Pitt-Hopkins Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79320",
    "phenodigmScore": 55.88,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003563 Decreased LDL cholesterol concentration,HP:0000546 Retinal degeneration,HP:0000510 Rod-cone dystrophy,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 20.22,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Alg6-Cdg",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:603278",
    "phenodigmScore": 59.57000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003077 Hyperlipidemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 27.6,
    "diseaseModelAvgRaw": 0.66,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Focal Segmental Glomerulosclerosis 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619312",
    "phenodigmScore": 46.33,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.7,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 82.96,
    "markerNumModels": 9,
    "diseaseTerm": "Radio-Tartaglia Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2655",
    "phenodigmScore": 44.599999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.63,
    "diseaseModelAvgRaw": 0.1,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 84.57,
    "markerNumModels": 9,
    "diseaseTerm": "Thanatophoric Dysplasia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:145600",
    "phenodigmScore": 49.925000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001649 Tachycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.87,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.98,
    "markerNumModels": 9,
    "diseaseTerm": "Malignant Hyperthermia, Susceptibility To, 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:370980",
    "phenodigmScore": 57.32,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001349 Facial diplegia,HP:0001302 Pachygyria,HP:0002500 Abnormal cerebral white matter morphology,HP:0002282 Gray matter heterotopia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.17,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 89.47,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Muscular Dystrophy Without Intellectual Disability",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:324442",
    "phenodigmScore": 46.81,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0012899 Handgrip myotonia,HP:0001771 Achilles tendon contracture,HP:0003760 Percussion-induced rapid rolling muscle contractions,HP:0001371 Flexion contracture,HP:0100490 Camptodactyly of finger",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 16.11,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Recessive Axonal Neuropathy With Neuromyotonia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99802",
    "phenodigmScore": 59.595,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0007206 Hemimegalencephaly,HP:0012757 Abnormal neuron morphology,HP:0001302 Pachygyria,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0032046 Focal cortical dysplasia,HP:0030890 Hyperintensity of cerebral white matter on MRI",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.2,
    "diseaseModelAvgRaw": 0.57,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 89.99,
    "markerNumModels": 9,
    "diseaseTerm": "Hemimegalencephaly",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1320",
    "phenodigmScore": 44.650000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0007354 Amyotrophic lateral sclerosis,HP:0100315 Lewy bodies,HP:0002500 Abnormal cerebral white matter morphology,HP:0002134 Abnormality of the basal ganglia,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 19.29,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0009937 abnormal neuron differentiation,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0003248 loss of glutamate neurons,MP:0002882 abnormal neuron morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 70.01,
    "markerNumModels": 9,
    "diseaseTerm": "Idiopathic Camptocormia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:427",
    "phenodigmScore": 49.15,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0011106 Hypovolemia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.23,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.07,
    "markerNumModels": 9,
    "diseaseTerm": "Familial Hypoaldosteronism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:86843",
    "phenodigmScore": 47.57,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 15.84,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Acute Panmyelosis With Myelofibrosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2315",
    "phenodigmScore": 48.93,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.62,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 89.24,
    "markerNumModels": 9,
    "diseaseTerm": "Johanson-Blizzard Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614196",
    "phenodigmScore": 56.61,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 27.28,
    "diseaseModelAvgRaw": 0.67,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.94,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 6",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:428",
    "phenodigmScore": 46.225,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001635 Congestive heart failure,HP:0000648 Optic atrophy,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.22,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.23,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Dominant Hypocalcemia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:267430",
    "phenodigmScore": 53.05,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.61,
    "diseaseModelAvgRaw": 0.52,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 82.49,
    "markerNumModels": 9,
    "diseaseTerm": "Renal Tubular Dysgenesis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615287",
    "phenodigmScore": 54.355,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002323 Anencephaly,HP:0001093 Optic nerve dysplasia,HP:0002282 Gray matter heterotopia,HP:0007260 Type II lissencephaly,HP:0002539 Cortical dysplasia,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 28.25,
    "diseaseModelAvgRaw": 0.61,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 80.46,
    "markerNumModels": 9,
    "diseaseTerm": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 13",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:37612",
    "phenodigmScore": 42.96,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 8.41,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Episodic Ataxia Type 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:601162",
    "phenodigmScore": 40.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.76,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 73.02,
    "markerNumModels": 9,
    "diseaseTerm": "Spastic Paraplegia 9A, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:247604",
    "phenodigmScore": 51.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.75,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 90.03,
    "markerNumModels": 9,
    "diseaseTerm": "Juvenile Primary Lateral Sclerosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100078",
    "phenodigmScore": 47.339999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0010446 Tricuspid stenosis,HP:0001962 Palpitations,HP:0025324 Arterial occlusion,HP:0001642 Pulmonic stenosis,HP:0030149 Cardiogenic shock,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.19,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.49,
    "markerNumModels": 9,
    "diseaseTerm": "Ileal Neuroendocrine Tumor",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:14",
    "phenodigmScore": 47.114999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007703 Abnormality of retinal pigmentation,HP:0003233 Decreased HDL cholesterol concentration,HP:0003146 Hypocholesterolemia,HP:0007894 Hypopigmentation of the fundus,HP:0025201 Abnormal circulating apolipoprotein concentration,HP:0000510 Rod-cone dystrophy,HP:0002904 Hyperbilirubinemia,HP:0012153 Hypotriglyceridemia,HP:0003073 Hypoalbuminemia,HP:0003563 Decreased LDL cholesterol concentration",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 14.27,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.96,
    "markerNumModels": 9,
    "diseaseTerm": "Abetalipoproteinemia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:65",
    "phenodigmScore": 49.16,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0012795 Abnormality of the optic disc",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.05,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 85.27,
    "markerNumModels": 9,
    "diseaseTerm": "Leber Congenital Amaurosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:168558",
    "phenodigmScore": 48.36,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008232 Elevated circulating follicle stimulating hormone level,HP:0011749 Adrenocorticotropic hormone excess,HP:0011106 Hypovolemia,HP:0011969 Elevated circulating luteinizing hormone level,HP:0001274 Agenesis of corpus callosum,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.65,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.07,
    "markerNumModels": 9,
    "diseaseTerm": "46,Xy Disorder Of Sex Development-Adrenal Insufficiency Due To Cyp11A1 Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:468631",
    "phenodigmScore": 46.275,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007333 Hypoplasia of the frontal lobes,HP:0000543 Optic disc pallor,HP:0007165 Periventricular heterotopia,HP:0000609 Optic nerve hypoplasia,HP:0009879 Simplified gyral pattern,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0002059 Cerebral atrophy,HP:0006872 Cerebral hypoplasia,HP:0002518 Abnormal periventricular white matter morphology,HP:0001339 Lissencephaly,HP:0002539 Cortical dysplasia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.86,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 71.69,
    "markerNumModels": 9,
    "diseaseTerm": "Microcephalic Cortical Malformations-Short Stature Due To Rttn Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:159",
    "phenodigmScore": 51.07,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004756 Ventricular tachycardia,HP:0001638 Cardiomyopathy,HP:0011675 Arrhythmia,HP:0000252 Microcephaly,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.67,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.47,
    "markerNumModels": 9,
    "diseaseTerm": "Carnitine-Acylcarnitine Translocase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79139",
    "phenodigmScore": 44.315,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003431 Decreased motor nerve conduction velocity,HP:0002060 Abnormal cerebral morphology,HP:0002339 Abnormal caudate nucleus morphology,HP:0045007 Abnormal substantia nigra morphology,HP:0010628 Facial palsy,HP:0002181 Cerebral edema,HP:0012502 Abnormality of the internal capsule,HP:0012692 Focal T2 hyperintense thalamic lesion,HP:0040272 Hyperintensity of MRI T2 signal of the spinal cord,HP:0010663 Abnormality of thalamus morphology,HP:0007277 Paucity of anterior horn motor neurons",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.57,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 74.06,
    "markerNumModels": 9,
    "diseaseTerm": "Japanese Encephalitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98892",
    "phenodigmScore": 44.97,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001659 Aortic regurgitation,HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.08,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 77.86,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Nodular Heterotopia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:205100",
    "phenodigmScore": 49.645,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.78,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 81.51,
    "markerNumModels": 9,
    "diseaseTerm": "Amyotrophic Lateral Sclerosis 2, Juvenile",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:109150",
    "phenodigmScore": 46.795,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002503 Spinocerebellar tract degeneration,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.28,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 84.31,
    "markerNumModels": 9,
    "diseaseTerm": "Machado-Joseph Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616437",
    "phenodigmScore": 53.945,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.34,
    "diseaseModelAvgRaw": 0.62,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 78.55,
    "markerNumModels": 9,
    "diseaseTerm": "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:352682",
    "phenodigmScore": 62.685,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0032398 Dysgyria,HP:0002500 Abnormal cerebral white matter morphology,HP:0002282 Gray matter heterotopia,HP:0007260 Type II lissencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 40.32,
    "diseaseModelAvgRaw": 0.84,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 85.05,
    "markerNumModels": 9,
    "diseaseTerm": "Cobblestone Lissencephaly Without Muscular Or Ocular Involvement",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:600351",
    "phenodigmScore": 61.07,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 31.02,
    "diseaseModelAvgRaw": 0.7,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Enteropathy, Familial, With Villous Edema And Immunoglobulin G2 Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:124",
    "phenodigmScore": 50.075,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0030270 Elevated red cell adenosine deaminase level,HP:0001875 Neutropenia,HP:0005518 Increased mean corpuscular volume,HP:0001882 Leukopenia,HP:0001895 Normochromic anemia,HP:0012410 Pure red cell aplasia,HP:0011904 Persistence of hemoglobin F,HP:0012133 Erythroid hypoplasia,HP:0004808 Acute myeloid leukemia,HP:0001896 Reticulocytopenia,HP:0001873 Thrombocytopenia,HP:0005532 Macrocytic dyserythropoietic anemia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 15.01,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 85.14,
    "markerNumModels": 9,
    "diseaseTerm": "Blackfan-Diamond Anemia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:241200",
    "phenodigmScore": 39.22,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002632 Low-to-normal blood pressure",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.09,
    "diseaseModelAvgRaw": 0.1,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.53,
    "diseaseModelMaxNorm": 74.35,
    "markerNumModels": 9,
    "diseaseTerm": "Bartter Syndrome, Type 2, Antenatal",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:361",
    "phenodigmScore": 45.83,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001639 Hypertrophic cardiomyopathy,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.34,
    "diseaseModelAvgRaw": 0.14,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.32,
    "markerNumModels": 9,
    "diseaseTerm": "Familial Glucocorticoid Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:297",
    "phenodigmScore": 43.08,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001291 Abnormal cranial nerve morphology,HP:3000047 Abnormal glossopharyngeal nerve morphology,HP:0010628 Facial palsy,HP:0012486 Myelitis,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.34,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 77.82,
    "markerNumModels": 9,
    "diseaseTerm": "Tick-Borne Encephalitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617622",
    "phenodigmScore": 45.040000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.54,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 81.54,
    "markerNumModels": 9,
    "diseaseTerm": "Joubert Syndrome 30",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616439",
    "phenodigmScore": 53.945,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.34,
    "diseaseModelAvgRaw": 0.62,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 78.55,
    "markerNumModels": 9,
    "diseaseTerm": "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 4",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:26793",
    "phenodigmScore": 50.66,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0030781 Increased circulating free fatty acid level,HP:0001987 Hyperammonemia,HP:0002901 Hypocalcemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 12.07,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 89.25,
    "markerNumModels": 9,
    "diseaseTerm": "Very Long Chain Acyl-Coa Dehydrogenase Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98849",
    "phenodigmScore": 48.230000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001279 Syncope,HP:0001974 Leukocytosis,HP:0005550 Chronic lymphatic leukemia,HP:0001897 Normocytic anemia,HP:0001895 Normochromic anemia,HP:0012325 Chronic myelomonocytic leukemia,HP:0001649 Tachycardia,HP:0001744 Splenomegaly,HP:0100494 Abnormal mast cell morphology,HP:0004808 Acute myeloid leukemia,HP:0005547 Myeloproliferative disorder,HP:0011897 Neutrophilia,HP:0031807 Increased basophil count,HP:0012324 Myeloid leukemia,HP:0001873 Thrombocytopenia,HP:0001880 Eosinophilia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 24.34,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009937 abnormal neuron differentiation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.21,
    "diseaseModelMaxNorm": 72.12,
    "markerNumModels": 9,
    "diseaseTerm": "Systemic Mastocytosis With Associated Hematologic Neoplasm",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:251643",
    "phenodigmScore": 56.775,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031938 Abnormal conus terminalis morphology,HP:0005341 Autonomic bladder dysfunction",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.56,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.35,
    "diseaseModelMaxNorm": 91.99,
    "markerNumModels": 9,
    "diseaseTerm": "Myxopapillary Ependymoma",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:235510",
    "phenodigmScore": 44.36,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 4.86,
    "diseaseModelAvgRaw": 0.11,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.86,
    "markerNumModels": 9,
    "diseaseTerm": "Hennekam Lymphangiectasia-Lymphedema Syndrome 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1314",
    "phenodigmScore": 63.015,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0011675 Arrhythmia,HP:0000252 Microcephaly,HP:0002514 Cerebral calcification",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 32.2,
    "diseaseModelAvgRaw": 0.64,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 93.83,
    "markerNumModels": 9,
    "diseaseTerm": "Symmetrical Thalamic Calcifications",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99147",
    "phenodigmScore": 49.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002170 Intracranial hemorrhage,HP:0001653 Mitral regurgitation,HP:0001659 Aortic regurgitation,HP:0000421 Epistaxis,HP:0005261 Joint hemorrhage,HP:0002249 Melena,HP:0001642 Pulmonic stenosis,HP:0002239 Gastrointestinal hemorrhage,HP:0001650 Aortic valve stenosis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.3,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.48,
    "markerNumModels": 9,
    "diseaseTerm": "Acquired Von Willebrand Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:464311",
    "phenodigmScore": 43.9,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000543 Optic disc pallor,HP:0011757 Posterior pituitary hypoplasia,HP:0001659 Aortic regurgitation,HP:0000252 Microcephaly,HP:0001650 Aortic valve stenosis,HP:0002079 Hypoplasia of the corpus callosum,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.23,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 75.57,
    "markerNumModels": 9,
    "diseaseTerm": "Intellectual Disability Syndrome Due To A Dyrk1A Point Mutation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:899",
    "phenodigmScore": 52.105,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0000648 Optic atrophy,HP:0002269 Abnormality of neuronal migration,HP:0001331 Absent septum pellucidum,HP:0001302 Pachygyria,HP:0007227 Macrogyria,HP:0002126 Polymicrogyria,HP:0001339 Lissencephaly,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 24.27,
    "diseaseModelAvgRaw": 0.52,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 79.94,
    "markerNumModels": 9,
    "diseaseTerm": "Walker-Warburg Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619281",
    "phenodigmScore": 57.519999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0010976 B lymphocytopenia,HP:0012311 Monocytosis,HP:0011897 Neutrophilia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 15.04,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Immunodeficiency 14B, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3307",
    "phenodigmScore": 53.145,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001279 Syncope,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.92,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 83.37,
    "markerNumModels": 9,
    "diseaseTerm": "Tetrasomy 18P",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:212138",
    "phenodigmScore": 50.785,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006682 Premature ventricular contraction,HP:0004756 Ventricular tachycardia,HP:0001678 Atrioventricular block,HP:0001638 Cardiomyopathy,HP:0001662 Bradycardia,HP:0001695 Cardiac arrest,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.72,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.85,
    "markerNumModels": 9,
    "diseaseTerm": "Carnitine-Acylcarnitine Translocase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:601678",
    "phenodigmScore": 39.425,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002632 Low-to-normal blood pressure",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.5,
    "diseaseModelAvgRaw": 0.11,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.53,
    "diseaseModelMaxNorm": 74.35,
    "markerNumModels": 9,
    "diseaseTerm": "Bartter Syndrome, Type 1, Antenatal",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615552",
    "phenodigmScore": 56.07000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.85,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Episodic Pain Syndrome, Familial, 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:521",
    "phenodigmScore": 55.775000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001912 Abnormal basophil morphology,HP:0001974 Leukocytosis,HP:0001911 Abnormal granulocyte morphology,HP:0001744 Splenomegaly,HP:0005547 Myeloproliferative disorder,HP:0001873 Thrombocytopenia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 23.51,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 88.04,
    "markerNumModels": 9,
    "diseaseTerm": "Chronic Myeloid Leukemia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:312700",
    "phenodigmScore": 61.99,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007401 Macular atrophy,HP:0000546 Retinal degeneration,HP:0030824 Mizuo phenomenon,HP:0007722 Retinal pigment epithelial atrophy,HP:0000541 Retinal detachment,HP:0007902 Vitreous hemorrhage,HP:0030502 Retinoschisis,HP:0007667 Peripheral cystoid retinal degeneration,HP:0001105 Retinal atrophy",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 49.72,
    "diseaseModelAvgRaw": 1.1,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.01,
    "diseaseModelMaxNorm": 74.26,
    "markerNumModels": 9,
    "diseaseTerm": "Retinoschisis 1, X-Linked, Juvenile",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:35107",
    "phenodigmScore": 49.565,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0002269 Abnormality of neuronal migration,HP:0001331 Absent septum pellucidum,HP:0001302 Pachygyria,HP:0007227 Macrogyria,HP:0002126 Polymicrogyria,HP:0001339 Lissencephaly,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.22,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 78.91,
    "markerNumModels": 9,
    "diseaseTerm": "Desmosterolosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:255800",
    "phenodigmScore": 45.870000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0003044 Shoulder flexion contracture,HP:0003273 Hip contracture,HP:0005830 Flexion contracture of toe,HP:0000939 Osteoporosis,HP:0009473 Joint contracture of the hand,HP:0001239 Wrist flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 14.23,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Schwartz-Jampel Syndrome, Type 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:221770",
    "phenodigmScore": 52.67,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002340 Caudate atrophy,HP:0002352 Leukoencephalopathy,HP:0002059 Cerebral atrophy,HP:0002135 Basal ganglia calcification,HP:0002079 Hypoplasia of the corpus callosum,HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.98,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 82.36,
    "markerNumModels": 9,
    "diseaseTerm": "Polycystic Lipomembranous Osteodysplasia With Sclerosing Leukoencephalopathy 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:202700",
    "phenodigmScore": 61.595,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001875 Neutropenia,HP:0012311 Monocytosis,HP:0005541 Congenital agranulocytosis,HP:0001903 Anemia,HP:0004845 Acute monocytic leukemia,HP:0001880 Eosinophilia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 23.19,
    "diseaseModelAvgRaw": 0.58,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009937 abnormal neuron differentiation,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Neutropenia, Severe Congenital, 1, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100075",
    "phenodigmScore": 47.644999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0007380 Facial telangiectasia,HP:0001962 Palpitations,HP:0005180 Tricuspid regurgitation,HP:0002249 Melena,HP:0030149 Cardiogenic shock,HP:0002248 Hematemesis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.43,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.86,
    "markerNumModels": 9,
    "diseaseTerm": "Neuroendocrine Tumor Of Stomach",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:329284",
    "phenodigmScore": 57.425,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0000648 Optic atrophy,HP:0012678 Iron accumulation in substantia nigra,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.66,
    "diseaseModelAvgRaw": 0.5,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.19,
    "markerNumModels": 9,
    "diseaseTerm": "Beta-Propeller Protein-Associated Neurodegeneration",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90695",
    "phenodigmScore": 46.835,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0040086 Abnormal prolactin level,HP:0000824 Decreased response to growth hormone stimulation test,HP:0008245 Pituitary hypothyroidism,HP:0010627 Anterior pituitary hypoplasia,HP:0040075 Hypopituitarism,HP:0012731 Ectopic anterior pituitary gland,HP:0011755 Ectopic posterior pituitary,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.38,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 73.29,
    "markerNumModels": 9,
    "diseaseTerm": "Non-Acquired Panhypopituitarism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607364",
    "phenodigmScore": 44.3,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.38,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.22,
    "markerNumModels": 9,
    "diseaseTerm": "Bartter Syndrome, Type 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3186",
    "phenodigmScore": 40.64,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.06,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 70.22,
    "markerNumModels": 9,
    "diseaseTerm": "Holoprosencephaly-Radial Heart Renal Anomalies Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608093",
    "phenodigmScore": 54.620000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001337 Tremor,HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 18.12,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001513 limb grasping,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Ij",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614563",
    "phenodigmScore": 56.57,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 26.58,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 86.56,
    "markerNumModels": 9,
    "diseaseTerm": "Mental Retardation, Autosomal Dominant 13",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:173",
    "phenodigmScore": 46.095,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031274 Hypovolemic shock,HP:0001649 Tachycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.67,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.52,
    "markerNumModels": 9,
    "diseaseTerm": "Cholera",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:293987",
    "phenodigmScore": 43.66,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy,HP:0008213 Gonadotropin deficiency,HP:0011748 Adrenocorticotropic hormone deficiency,HP:0000863 Central diabetes insipidus,HP:0000824 Decreased response to growth hormone stimulation test,HP:0000870 Increased circulating prolactin concentration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 7.33,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0001501 abnormal sleep pattern,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Rapid-Onset Childhood Obesity-Hypothalamic Dysfunction-Hypoventilation-Autonomic Dysregulation Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:256800",
    "phenodigmScore": 45.25,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0005307 Postural hypotension with compensatory tachycardia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.47,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.03,
    "markerNumModels": 9,
    "diseaseTerm": "Insensitivity To Pain, Congenital, With Anhidrosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:260450",
    "phenodigmScore": 55.115,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 27.48,
    "diseaseModelAvgRaw": 0.79,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 82.75,
    "markerNumModels": 9,
    "diseaseTerm": "Pancreatic insufficiency, combined exocrine",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:86816",
    "phenodigmScore": 55.545,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003077 Hyperlipidemia,HP:0003124 Hypercholesterolemia,HP:0003073 Hypoalbuminemia,HP:0005413 Increased alpha-globulin",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 27.4,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 83.69,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Analbuminemia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:236680",
    "phenodigmScore": 41.73,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0002139 Arrhinencephaly,HP:0002323 Anencephaly,HP:0001331 Absent septum pellucidum,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.94,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 65.52,
    "markerNumModels": 9,
    "diseaseTerm": "Hydrolethalus Syndrome 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:26791",
    "phenodigmScore": 42.730000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001638 Cardiomyopathy,HP:0011675 Arrhythmia,HP:0001635 Congestive heart failure",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.98,
    "diseaseModelAvgRaw": 0.15,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 78.48,
    "markerNumModels": 9,
    "diseaseTerm": "Multiple Acyl-Coa Dehydrogenase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618677",
    "phenodigmScore": 64.24000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002079 Hypoplasia of the corpus callosum,HP:0006891 Thick cerebral cortex,HP:0001339 Lissencephaly,HP:0032390 Periventricular ribbonlike heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 30.17,
    "diseaseModelAvgRaw": 0.57,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 98.31,
    "markerNumModels": 9,
    "diseaseTerm": "Cortical Dysplasia, Complex, With Other Brain Malformations 10",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:94124",
    "phenodigmScore": 55.94500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003124 Hypercholesterolemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 20.35,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Spinocerebellar Ataxia With Axonal Neuropathy Type 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:210710",
    "phenodigmScore": 41.125,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007333 Hypoplasia of the frontal lobes,HP:0001302 Pachygyria,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.76,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 69.49,
    "markerNumModels": 9,
    "diseaseTerm": "Microcephalic Osteodysplastic Primordial Dwarfism, Type I",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2162",
    "phenodigmScore": 43.835,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000648 Optic atrophy,HP:0000871 Panhypopituitarism,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0000830 Anterior hypopituitarism,HP:0010302 Spinal cord tumor,HP:0010301 Spinal dysraphism,HP:0011675 Arrhythmia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.69,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 76.98,
    "markerNumModels": 9,
    "diseaseTerm": "Holoprosencephaly",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:171695",
    "phenodigmScore": 47.72,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011960 Substantia nigra gliosis,HP:0100315 Lewy bodies,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.34,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 76.1,
    "markerNumModels": 9,
    "diseaseTerm": "Parkinsonian-Pyramidal Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:289548",
    "phenodigmScore": 48.265,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008232 Elevated circulating follicle stimulating hormone level,HP:0011749 Adrenocorticotropic hormone excess,HP:0011106 Hypovolemia,HP:0011969 Elevated circulating luteinizing hormone level,HP:0001274 Agenesis of corpus callosum,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.46,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.07,
    "markerNumModels": 9,
    "diseaseTerm": "Inherited Isolated Adrenal Insufficiency Due To Partial Cyp11A1 Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:529799",
    "phenodigmScore": 48.285,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia,HP:0003228 Hypernatremia,HP:0003265 Neonatal hyperbilirubinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 16.86,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.71,
    "markerNumModels": 9,
    "diseaseTerm": "Acute Bilirubin Encephalopathy",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:606170",
    "phenodigmScore": 40.005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030048 Colpocephaly,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly,HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.99,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 63.02,
    "markerNumModels": 9,
    "diseaseTerm": "Genitopatellar Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:300337",
    "phenodigmScore": 52.31,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0000252 Microcephaly,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.97,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 85.65,
    "markerNumModels": 9,
    "diseaseTerm": "Hypomelanosis Of Ito",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:88618",
    "phenodigmScore": 49.175,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002160 Hyperhomocystinemia,HP:0003236 Elevated circulating creatine kinase concentration,HP:0010901 Abnormal circulating methionine concentration,HP:0010919 Abnormal circulating homocysteine concentration,HP:0003073 Hypoalbuminemia,HP:0003235 Hypermethioninemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 14.77,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.58,
    "markerNumModels": 9,
    "diseaseTerm": "S-Adenosylhomocysteine Hydrolase Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:254450",
    "phenodigmScore": 51.485,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 23.67,
    "diseaseModelAvgRaw": 0.61,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Myelofibrosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607641",
    "phenodigmScore": 55.620000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010628 Facial palsy,HP:0002366 Abnormal lower motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.21,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 90.03,
    "markerNumModels": 9,
    "diseaseTerm": "Neuronopathy, Distal Hereditary Motor, Type Viib",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:84064",
    "phenodigmScore": 50.849999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0011877 Increased mean platelet volume,HP:0001659 Aortic regurgitation,HP:0000778 Hypoplasia of the thymus,HP:0001643 Patent ductus arteriosus,HP:0001744 Splenomegaly,HP:0001888 Lymphopenia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.99,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 87.71,
    "markerNumModels": 9,
    "diseaseTerm": "Syndromic Diarrhea",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619487",
    "phenodigmScore": 46.55,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0000533 Chorioretinal atrophy,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.38,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 84.72,
    "markerNumModels": 9,
    "diseaseTerm": "Aicardi-Goutieres Syndrome 9",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1467",
    "phenodigmScore": 53.88,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0001659 Aortic regurgitation,HP:0001903 Anemia,HP:0005310 Large vessel vasculitis,HP:0002633 Vasculitis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 23.98,
    "diseaseModelAvgRaw": 0.6,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 83.78,
    "markerNumModels": 9,
    "diseaseTerm": "Cogan Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:991",
    "phenodigmScore": 45.295,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002435 Meningocele,HP:0000648 Optic atrophy,HP:0002269 Abnormality of neuronal migration,HP:0002414 Spina bifida,HP:0001645 Sudden cardiac death,HP:0011675 Arrhythmia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.34,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 69.25,
    "markerNumModels": 9,
    "diseaseTerm": "Pagod Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:97292",
    "phenodigmScore": 53.220000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0001653 Mitral regurgitation,HP:0030851 Low pulse pressure,HP:0030848 Elevated jugular venous pressure,HP:0009805 Low-output congestive heart failure,HP:0012251 ST segment elevation,HP:0030876 Increased pulmonary capillary wedge pressure,HP:0001658 Myocardial infarction,HP:0001695 Cardiac arrest,HP:0001635 Congestive heart failure,HP:0003115 Abnormal EKG,HP:0005162 Abnormal left ventricular function,HP:0006670 Impaired myocardial contractility,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.01,
    "diseaseModelAvgRaw": 0.58,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.43,
    "markerNumModels": 9,
    "diseaseTerm": "Cardiogenic Shock",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:86841",
    "phenodigmScore": 58.9,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001972 Macrocytic anemia,HP:0001882 Leukopenia,HP:0012133 Erythroid hypoplasia,HP:0004808 Acute myeloid leukemia,HP:0011273 Anisocytosis,HP:0001877 Abnormal erythrocyte morphology,HP:0011992 Abnormality of neutrophil morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 20.56,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 97.24,
    "markerNumModels": 9,
    "diseaseTerm": "Myelodysplastic Syndrome Associated With Isolated Del(5Q) Chromosome Abnormality",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:168300",
    "phenodigmScore": 50.71,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012899 Handgrip myotonia,HP:0011809 Paradoxical myotonia,HP:0010548 Percussion myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 25.13,
    "diseaseModelAvgRaw": 0.54,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 76.29,
    "markerNumModels": 9,
    "diseaseTerm": "Paramyotonia Congenita Of Von Eulenburg",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:217253",
    "phenodigmScore": 41.475,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0012333 Abnormal sudomotor regulation,HP:0012173 Orthostatic tachycardia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.39,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 70.56,
    "markerNumModels": 9,
    "diseaseTerm": "Limbic Encephalitis With Nmda Receptor Antibodies",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614039",
    "phenodigmScore": 64.86500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001339 Lissencephaly,HP:0002126 Polymicrogyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0002539 Cortical dysplasia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 46.36,
    "diseaseModelAvgRaw": 0.89,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 83.37,
    "markerNumModels": 9,
    "diseaseTerm": "Cortical Dysplasia, Complex, With Other Brain Malformations 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:71273",
    "phenodigmScore": 44.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0001279 Syncope,HP:0001649 Tachycardia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.78,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 73.72,
    "markerNumModels": 9,
    "diseaseTerm": "Renal Nutcracker Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:267700",
    "phenodigmScore": 55.2,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0003075 Hypoproteinemia,HP:0003233 Decreased HDL cholesterol concentration,HP:0003141 Increased LDL cholesterol concentration,HP:0003362 Increased VLDL cholesterol concentration,HP:0003573 Increased total bilirubin,HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 21.68,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 88.72,
    "markerNumModels": 9,
    "diseaseTerm": "Hemophagocytic Lymphohistiocytosis, Familial, 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2216",
    "phenodigmScore": 57.375,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.46,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 95.29,
    "markerNumModels": 9,
    "diseaseTerm": "Maternal Hyperthermia-Induced Birth Defects",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:170600",
    "phenodigmScore": 47.765,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 18.02,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Normokalemic Periodic Paralysis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:231550",
    "phenodigmScore": 49.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0000648 Optic atrophy,HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.22,
    "diseaseModelAvgRaw": 0.54,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 75.81,
    "markerNumModels": 9,
    "diseaseTerm": "Achalasia-Addisonianism-Alacrima Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79327",
    "phenodigmScore": 50.245000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 11.46,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 89.03,
    "markerNumModels": 9,
    "diseaseTerm": "Alg1-Cdg",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:101016",
    "phenodigmScore": 52.835,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001279 Syncope,HP:0001688 Sinus bradycardia,HP:0005135 Abnormal T-wave,HP:0004308 Ventricular arrhythmia,HP:0001664 Torsade de pointes,HP:0005184 Prolonged QTc interval,HP:0001645 Sudden cardiac death,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 27.64,
    "diseaseModelAvgRaw": 0.62,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.03,
    "markerNumModels": 9,
    "diseaseTerm": "Romano-Ward Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618185",
    "phenodigmScore": 64.7,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032388 Periventricular nodular heterotopia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.4,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Nodular Heterotopia 8",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2065",
    "phenodigmScore": 46.08,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001302 Pachygyria,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.24,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 75.92,
    "markerNumModels": 9,
    "diseaseTerm": "Galloway-Mowat Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617729",
    "phenodigmScore": 44.235,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 7.19,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 81.28,
    "markerNumModels": 9,
    "diseaseTerm": "Galloway-Mowat Syndrome 3",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616604",
    "phenodigmScore": 54.76,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 30.22,
    "diseaseModelAvgRaw": 0.88,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Chromosome 14Q32 Duplication Syndrome, 700-Kb",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79155",
    "phenodigmScore": 48.975,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001649 Tachycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.5,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.45,
    "markerNumModels": 9,
    "diseaseTerm": "Hydroxykynureninuria",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:174900",
    "phenodigmScore": 45.525000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002900 Hypokalemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 17.65,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 73.4,
    "markerNumModels": 9,
    "diseaseTerm": "Juvenile Polyposis Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2211",
    "phenodigmScore": 47.175,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0002269 Abnormality of neuronal migration,HP:0001302 Pachygyria,HP:0007227 Macrogyria,HP:0002126 Polymicrogyria,HP:0001339 Lissencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.55,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 73.8,
    "markerNumModels": 9,
    "diseaseTerm": "Hypertelorism-Hypospadias-Polysyndactyly Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614521",
    "phenodigmScore": 57.21,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 14.42,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Thrombocythemia 3",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:85445",
    "phenodigmScore": 48.88,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.29,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 90.47,
    "markerNumModels": 9,
    "diseaseTerm": "Aa Amyloidosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:301500",
    "phenodigmScore": 48.075,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001681 Angina pectoris,HP:0001658 Myocardial infarction,HP:0002326 Transient ischemic attack,HP:0001635 Congestive heart failure,HP:0011675 Arrhythmia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.75,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 79.4,
    "markerNumModels": 9,
    "diseaseTerm": "Fabry Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614131",
    "phenodigmScore": 57.785000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 24.03,
    "diseaseModelAvgRaw": 0.56,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Focal Segmental Glomerulosclerosis 6",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:330021",
    "phenodigmScore": 53.86,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001649 Tachycardia,HP:0002615 Hypotension,HP:0002500 Abnormal cerebral white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.37,
    "diseaseModelAvgRaw": 0.5,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.35,
    "markerNumModels": 9,
    "diseaseTerm": "Mercury Poisoning",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:567546",
    "phenodigmScore": 43.855,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003077 Hyperlipidemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 11.55,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 76.16,
    "markerNumModels": 9,
    "diseaseTerm": "Idiopathic Steroid-Sensitive Nephrotic Syndrome With Secondary Steroid Resistance",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617780",
    "phenodigmScore": 57.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001972 Macrocytic anemia,HP:0001889 Megaloblastic anemia,HP:0001888 Lymphopenia,HP:0001876 Pancytopenia,HP:0010972 Anemia of inadequate production",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 16.99,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 98.51,
    "markerNumModels": 9,
    "diseaseTerm": "Combined Immunodeficiency And Megaloblastic Anemia With Or Without Hyperhomocysteinemia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:161400",
    "phenodigmScore": 46.415,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 12.84,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001501 abnormal sleep pattern",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Narcolepsy 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614044",
    "phenodigmScore": 66.61,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 42.1,
    "diseaseModelAvgRaw": 1.02,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Trypsinogen Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:261537",
    "phenodigmScore": 37.595,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0040331 Focal hypointensity of cerebral white matter on MRI,HP:0002251 Aganglionic megacolon,HP:0012430 Cerebral white matter hypoplasia,HP:0007048 Large basal ganglia,HP:0007165 Periventricular heterotopia,HP:0001273 Abnormal corpus callosum morphology,HP:0011451 Primary microcephaly,HP:0001642 Pulmonic stenosis,HP:0002126 Polymicrogyria,HP:0001650 Aortic valve stenosis,HP:0006956 Dilation of lateral ventricles,HP:0005484 Secondary microcephaly,HP:0002079 Hypoplasia of the corpus callosum,HP:0025100 Abnormal hippocampus morphology,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.37,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 63.82,
    "markerNumModels": 9,
    "diseaseTerm": "Mowat-Wilson Syndrome Due To Monosomy 2Q22",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:183020",
    "phenodigmScore": 54.975,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006802 Abnormal anterior horn cell morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.92,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 90.03,
    "markerNumModels": 9,
    "diseaseTerm": "Spinal Muscular Atrophy, Segmental",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90791",
    "phenodigmScore": 47.584999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011749 Adrenocorticotropic hormone excess,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.85,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.32,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Adrenal Hyperplasia Due To 3-Beta-Hydroxysteroid Dehydrogenase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:105210",
    "phenodigmScore": 48.64,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0001638 Cardiomyopathy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.53,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 83.75,
    "markerNumModels": 9,
    "diseaseTerm": "Amyloidosis, Hereditary, Transthyretin-Related",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:256300",
    "phenodigmScore": 56.97,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003077 Hyperlipidemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 22.82,
    "diseaseModelAvgRaw": 0.53,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:609136",
    "phenodigmScore": 46.835,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004463 Absent brainstem auditory responses,HP:0000762 Decreased nerve conduction velocity,HP:0011285 Long-segment aganglionic megacolon,HP:0007266 Cerebral dysmyelination,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.28,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 77.39,
    "markerNumModels": 9,
    "diseaseTerm": "Peripheral Demyelinating Neuropathy, Central Dysmyelination, Waardenburg Syndrome, And Hirschsprung Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:371",
    "phenodigmScore": 46.68000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0001903 Anemia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 15.96,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.4,
    "markerNumModels": 9,
    "diseaseTerm": "Glycogen Storage Disease Due To Muscle Phosphofructokinase Deficiency",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100077",
    "phenodigmScore": 47.339999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0010446 Tricuspid stenosis,HP:0001962 Palpitations,HP:0025324 Arterial occlusion,HP:0001642 Pulmonic stenosis,HP:0030149 Cardiogenic shock,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.19,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.49,
    "markerNumModels": 9,
    "diseaseTerm": "Jejunal Neuroendocrine Tumor",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:241600",
    "phenodigmScore": 63.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 36.66,
    "diseaseModelAvgRaw": 0.95,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Immunodeficiency 43",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:209880",
    "phenodigmScore": 42.605000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002251 Aganglionic megacolon,HP:0031861 Decreased heart rate variability,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.06,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 74.15,
    "markerNumModels": 9,
    "diseaseTerm": "Central Hypoventilation Syndrome, Congenital, 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2929",
    "phenodigmScore": 41.14,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 5.72,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 76.56,
    "markerNumModels": 9,
    "diseaseTerm": "Juvenile Polyposis Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:199296",
    "phenodigmScore": 47.985,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.65,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.32,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Isolated Acth Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:602668",
    "phenodigmScore": 48.394999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001962 Palpitations,HP:0002486 Myotonia,HP:0001649 Tachycardia,HP:0008232 Elevated circulating follicle stimulating hormone level",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 21.16,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 75.63,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonic Dystrophy 2",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:158800",
    "phenodigmScore": 47.165000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 16.82,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Muscular Dystrophy, Barnes Type",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99736",
    "phenodigmScore": 44.68,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 11.85,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Acetazolamide-Responsive Myotonia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:222470",
    "phenodigmScore": 50.735,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001659 Aortic regurgitation,HP:0011877 Increased mean platelet volume,HP:0001642 Pulmonic stenosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 11.31,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 90.16,
    "markerNumModels": 9,
    "diseaseTerm": "Trichohepatoenteric Syndrome 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2965",
    "phenodigmScore": 49.47,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011748 Adrenocorticotropic hormone deficiency,HP:0008245 Pituitary hypothyroidism,HP:0008240 Secondary growth hormone deficiency,HP:0012503 Abnormality of the pituitary gland,HP:0000830 Anterior hypopituitarism,HP:0000845 Elevated circulating growth hormone concentration,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.08,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.86,
    "markerNumModels": 9,
    "diseaseTerm": "Prolactinoma",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614887",
    "phenodigmScore": 48.88,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.84,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 88.92,
    "markerNumModels": 9,
    "diseaseTerm": "Peroxisome Biogenesis Disorder 13A (Zellweger)",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:212065",
    "phenodigmScore": 53.74,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001638 Cardiomyopathy,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.48,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 94.0,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Ia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:188",
    "phenodigmScore": 49.055,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0011675 Arrhythmia,HP:0001701 Pericarditis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.64,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.47,
    "markerNumModels": 9,
    "diseaseTerm": "Systemic Capillary Leak Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1493",
    "phenodigmScore": 50.875,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0001638 Cardiomyopathy,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.29,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 78.46,
    "markerNumModels": 9,
    "diseaseTerm": "Vici Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:97229",
    "phenodigmScore": 56.795,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001291 Abnormal cranial nerve morphology,HP:0000543 Optic disc pallor,HP:0010628 Facial palsy,HP:0002120 Cerebral cortical atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.3,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Riboflavin Transporter Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:214100",
    "phenodigmScore": 44.155,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000543 Optic disc pallor,HP:0006894 Hypoplastic olfactory lobes,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.02,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 77.29,
    "markerNumModels": 9,
    "diseaseTerm": "Peroxisome Biogenesis Disorder 1A (Zellweger)",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:187900",
    "phenodigmScore": 54.39,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis,HP:0002239 Gastrointestinal hemorrhage,HP:0000421 Epistaxis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 29.48,
    "diseaseModelAvgRaw": 0.73,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Bleeding Disorder, Platelet-Type, 17",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:221400",
    "phenodigmScore": 60.2,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 29.28,
    "diseaseModelAvgRaw": 0.71,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Deafness, Nerve Type, With Mesenteric Diverticula Of Small Bowel And Progressive Sensory Neuropathy",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619652",
    "phenodigmScore": 52.715,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0010976 B lymphocytopenia,HP:0030388 Decreased proportion of class-switched memory B cells,HP:0001894 Thrombocytosis,HP:0100827 Lymphocytosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.46,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 91.97,
    "markerNumModels": 9,
    "diseaseTerm": "Immunodeficiency 92",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:314679",
    "phenodigmScore": 46.900000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006989 Dysplastic corpus callosum,HP:0001642 Pulmonic stenosis,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.04,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 74.76,
    "markerNumModels": 9,
    "diseaseTerm": "Cerebrofacioarticular Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:656",
    "phenodigmScore": 48.769999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 14.8,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 82.74,
    "markerNumModels": 9,
    "diseaseTerm": "Genetic Steroid-Resistant Nephrotic Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:43116",
    "phenodigmScore": 49.825,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0002270 Abnormality of the autonomic nervous system,HP:0002615 Hypotension,HP:0001649 Tachycardia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.53,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.12,
    "markerNumModels": 9,
    "diseaseTerm": "Serotonin Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619534",
    "phenodigmScore": 39.415,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003259 Elevated circulating creatinine concentration,HP:0002904 Hyperbilirubinemia,HP:0003124 Hypercholesterolemia,HP:0003281 Increased circulating ferritin concentration,HP:0002908 Conjugated hyperbilirubinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 5.38,
    "diseaseModelAvgRaw": 0.12,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 73.45,
    "markerNumModels": 9,
    "diseaseTerm": "Biliary, Renal, Neurologic, And Skeletal Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100079",
    "phenodigmScore": 46.85,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010446 Tricuspid stenosis,HP:0001962 Palpitations,HP:0002615 Hypotension,HP:0011749 Adrenocorticotropic hormone excess,HP:0030148 Heart murmur",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.62,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 78.08,
    "markerNumModels": 9,
    "diseaseTerm": "Neuroendocrine Neoplasm Of Appendix",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79396",
    "phenodigmScore": 42.71,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 6.9,
    "diseaseModelAvgRaw": 0.15,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 78.52,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Dominant Generalized Epidermolysis Bullosa Simplex, Severe Form",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615219",
    "phenodigmScore": 53.615,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0030048 Colpocephaly,HP:0009879 Simplified gyral pattern,HP:0002282 Gray matter heterotopia,HP:0001339 Lissencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 33.5,
    "diseaseModelAvgRaw": 0.71,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 73.73,
    "markerNumModels": 9,
    "diseaseTerm": "Hydrocephalus, Congenital, 2, With Or Without Brain Or Eye Anomalies",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:549",
    "phenodigmScore": 48.55,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0011675 Arrhythmia,HP:0001701 Pericarditis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.91,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.19,
    "markerNumModels": 9,
    "diseaseTerm": "Legionnaires Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:507",
    "phenodigmScore": 48.945,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.86,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 87.03,
    "markerNumModels": 9,
    "diseaseTerm": "Leishmaniasis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:236800",
    "phenodigmScore": 57.31,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001649 Tachycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.62,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Hydroxykynureninuria",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2494",
    "phenodigmScore": 54.45,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 19.17,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 89.73,
    "markerNumModels": 9,
    "diseaseTerm": "M√©n√©trier Disease",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:453499",
    "phenodigmScore": 46.445,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003396 Syringomyelia,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.89,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 80.0,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder-Craniofacial Dysmorphism-Cardiac Defect-Skeletal Anomalies Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:158048",
    "phenodigmScore": 57.855000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia,HP:0002152 Hyperproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.71,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 3.34,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Hemophagocytic Syndrome Associated With An Infection",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:71493",
    "phenodigmScore": 56.31,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001279 Syncope,HP:0001894 Thrombocytosis,HP:0002092 Pulmonary arterial hypertension,HP:0002637 Cerebral ischemia,HP:0001744 Splenomegaly,HP:0005506 Chronic myelogenous leukemia,HP:0004808 Acute myeloid leukemia,HP:0002326 Transient ischemic attack",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 27.89,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 84.73,
    "markerNumModels": 9,
    "diseaseTerm": "Familial Thrombocytosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:540",
    "phenodigmScore": 46.96,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 9.81,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 84.11,
    "markerNumModels": 9,
    "diseaseTerm": "Familial Hemophagocytic Lymphohistiocytosis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98850",
    "phenodigmScore": 49.214999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001875 Neutropenia,HP:0001873 Thrombocytopenia,HP:0001909 Leukemia,HP:0001903 Anemia,HP:0100494 Abnormal mast cell morphology,HP:0002239 Gastrointestinal hemorrhage,HP:0001433 Hepatosplenomegaly,HP:0001971 Hypersplenism,HP:0001876 Pancytopenia,HP:0031408 Increased proportion of CD25+ mast cells,HP:0001409 Portal hypertension,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 22.86,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.21,
    "diseaseModelMaxNorm": 75.57,
    "markerNumModels": 9,
    "diseaseTerm": "Aggressive Systemic Mastocytosis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:177735",
    "phenodigmScore": 48.495000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.37,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.62,
    "markerNumModels": 9,
    "diseaseTerm": "Pseudohypoaldosteronism, Type I, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79456",
    "phenodigmScore": 48.275000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002239 Gastrointestinal hemorrhage,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.62,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 88.93,
    "markerNumModels": 9,
    "diseaseTerm": "Diffuse Cutaneous Mastocytosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:163681",
    "phenodigmScore": 46.12,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012757 Abnormal neuron morphology,HP:0002269 Abnormality of neuronal migration,HP:0006970 Periventricular leukomalacia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.22,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 78.02,
    "markerNumModels": 9,
    "diseaseTerm": "Cntnap2-Related Developmental And Epileptic Encephalopathy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:227090",
    "phenodigmScore": 62.43,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 38.16,
    "diseaseModelAvgRaw": 0.84,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 86.7,
    "markerNumModels": 9,
    "diseaseTerm": "Erythroderma, Lethal Congenital",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:164180",
    "phenodigmScore": 54.629999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 26.79,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 82.47,
    "markerNumModels": 9,
    "diseaseTerm": "Oculocerebrocutaneous Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:602099",
    "phenodigmScore": 49.025,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.5,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 78.55,
    "markerNumModels": 9,
    "diseaseTerm": "Amyotrophic Lateral Sclerosis 5, Juvenile",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617303",
    "phenodigmScore": 47.305,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0040030 Chorioretinal hypopigmentation,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.44,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 86.17,
    "markerNumModels": 9,
    "diseaseTerm": "Mucopolysaccharidosis-Plus Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:105550",
    "phenodigmScore": 51.065,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.58,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 78.55,
    "markerNumModels": 9,
    "diseaseTerm": "Frontotemporal Dementia And/Or Amyotrophic Lateral Sclerosis 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:187950",
    "phenodigmScore": 59.78,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0008148 Impaired epinephrine-induced platelet aggregation,HP:0008320 Impaired collagen-induced platelet aggregation,HP:0001744 Splenomegaly,HP:0004866 Impaired ADP-induced platelet aggregation",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 19.56,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Thrombocythemia 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:391673",
    "phenodigmScore": 48.160000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0001662 Bradycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.84,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.48,
    "markerNumModels": 9,
    "diseaseTerm": "Necrotizing Enterocolitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2754",
    "phenodigmScore": 42.65,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002444 Hypothalamic hamartoma,HP:0002269 Abnormality of neuronal migration,HP:0007370 Aplasia/Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.73,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 75.57,
    "markerNumModels": 9,
    "diseaseTerm": "Orofaciodigital Syndrome Type 6",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:215470",
    "phenodigmScore": 44.18,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.22,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.14,
    "markerNumModels": 9,
    "diseaseTerm": "Boucher-Neuhauser Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:255710",
    "phenodigmScore": 44.910000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 12.31,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonia With Skeletal Abnormalities And Mental Retardation",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:29073",
    "phenodigmScore": 57.65,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002152 Hyperproteinemia,HP:0003259 Elevated circulating creatinine concentration,HP:0003072 Hypercalcemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.3,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 3.34,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Multiple Myeloma",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:340",
    "phenodigmScore": 46.23,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0000822 Hypertension,HP:0002170 Intracranial hemorrhage,HP:0001962 Palpitations,HP:0011896 Subconjunctival hemorrhage,HP:0000421 Epistaxis,HP:0001649 Tachycardia,HP:0002249 Melena,HP:0002248 Hematemesis,HP:0002615 Hypotension,HP:0011029 Internal hemorrhage,HP:0030005 Capillary leak",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.6,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.86,
    "markerNumModels": 9,
    "diseaseTerm": "Hemorrhagic Fever-Renal Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90051",
    "phenodigmScore": 46.28,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001649 Tachycardia,HP:0002615 Hypotension,HP:0001662 Bradycardia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.09,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.47,
    "markerNumModels": 9,
    "diseaseTerm": "Sepsis In Premature Infants",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98863",
    "phenodigmScore": 47.735,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001639 Hypertrophic cardiomyopathy,HP:0002486 Myotonia,HP:0005155 Ventricular escape rhythm,HP:0001678 Atrioventricular block,HP:0001771 Achilles tendon contracture,HP:0004631 Decreased cervical spine flexion due to contractures of posterior cervical muscles,HP:0001387 Joint stiffness,HP:0001645 Sudden cardiac death,HP:0005115 Supraventricular arrhythmia,HP:0002987 Elbow flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 17.96,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "X-Linked Emery-Dreifuss Muscular Dystrophy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:253310",
    "phenodigmScore": 43.14,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007277 Paucity of anterior horn motor neurons",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.77,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 73.51,
    "markerNumModels": 9,
    "diseaseTerm": "Lethal Congenital Contracture Syndrome 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616730",
    "phenodigmScore": 49.495000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003124 Hypercholesterolemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 13.73,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.26,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 11",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1454",
    "phenodigmScore": 44.93000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001409 Portal hypertension,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0000588 Optic disc coloboma",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.93,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 76.93,
    "markerNumModels": 9,
    "diseaseTerm": "Joubert Syndrome With Hepatic Defect",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:330001",
    "phenodigmScore": 52.6,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001639 Hypertrophic cardiomyopathy,HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0001662 Bradycardia,HP:0001658 Myocardial infarction,HP:0005341 Autonomic bladder dysfunction,HP:0001635 Congestive heart failure,HP:0003115 Abnormal EKG,HP:0011675 Arrhythmia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.5,
    "diseaseModelAvgRaw": 0.53,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 82.7,
    "markerNumModels": 9,
    "diseaseTerm": "Wild Type Attr Amyloidosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:312550",
    "phenodigmScore": 75.0,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001493 Falciform retinal fold,HP:0007973 Retinal dysplasia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 50.0,
    "diseaseModelAvgRaw": 0.96,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.09,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Retinal Dysplasia, Primary",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:602433",
    "phenodigmScore": 55.379999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006825 Pallor of dorsal columns of the spinal cord,HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002127 Abnormal upper motor neuron morphology,HP:0002398 Degeneration of anterior horn cells",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.85,
    "diseaseModelAvgRaw": 0.6,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 80.91,
    "markerNumModels": 9,
    "diseaseTerm": "Amyotrophic Lateral Sclerosis 4, Juvenile",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:37042",
    "phenodigmScore": 44.415,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031085 Decreased prealbumin level,HP:0002901 Hypocalcemia,HP:0002917 Hypomagnesemia,HP:0003073 Hypoalbuminemia,HP:0003111 Abnormal blood ion concentration",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.1,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 80.73,
    "markerNumModels": 9,
    "diseaseTerm": "Immune Dysregulation-Polyendocrinopathy-Enteropathy-X-Linked Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:31824",
    "phenodigmScore": 47.464999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0030149 Cardiogenic shock,HP:0001635 Congestive heart failure,HP:0011106 Hypovolemia,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.86,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.07,
    "markerNumModels": 9,
    "diseaseTerm": "Colchicine Poisoning",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618918",
    "phenodigmScore": 44.04,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032388 Periventricular nodular heterotopia,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.25,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 66.83,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Nodular Heterotopia 9",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2968",
    "phenodigmScore": 45.5,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001901 Polycythemia,HP:0004808 Acute myeloid leukemia,HP:0011990 Abnormality of neutrophil physiology,HP:0002059 Cerebral atrophy,HP:0040238 Impaired neutrophil chemotaxis,HP:0003540 Impaired platelet aggregation,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 11.76,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 79.24,
    "markerNumModels": 9,
    "diseaseTerm": "Leukocyte Adhesion Deficiency",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2388",
    "phenodigmScore": 42.65,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0002340 Caudate atrophy,HP:0007078 Decreased amplitude of sensory action potentials,HP:0031982 Abnormal putamen morphology,HP:0006913 Frontal cortical atrophy,HP:0025517 Hypoplastic hippocampus,HP:0012697 Small basal ganglia,HP:0006956 Dilation of lateral ventricles,HP:0025100 Abnormal hippocampus morphology,HP:0002120 Cerebral cortical atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.0,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 71.3,
    "markerNumModels": 9,
    "diseaseTerm": "Choreoacanthocytosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3101",
    "phenodigmScore": 49.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006462 Generalized bone demineralization,HP:0012903 Myotonia of the upper limb,HP:0012899 Handgrip myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 23.83,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 75.2,
    "markerNumModels": 9,
    "diseaseTerm": "Richieri Costa-Da Silva Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:604213",
    "phenodigmScore": 70.345,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001338 Partial agenesis of the corpus callosum,HP:0006989 Dysplastic corpus callosum,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 45.2,
    "diseaseModelAvgRaw": 0.94,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 95.49,
    "markerNumModels": 9,
    "diseaseTerm": "Chudley-Mccullough Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:243180",
    "phenodigmScore": 54.925,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002251 Aganglionic megacolon,HP:0032466 Aplasia of the olfactory bulb,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.44,
    "diseaseModelAvgRaw": 0.53,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 84.41,
    "markerNumModels": 9,
    "diseaseTerm": "Visceral Neuropathy, Familial, 1, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:226200",
    "phenodigmScore": 65.505,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 39.89,
    "diseaseModelAvgRaw": 0.89,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Enterokinase Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:252320",
    "phenodigmScore": 53.095,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0000762 Decreased nerve conduction velocity,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.7,
    "diseaseModelAvgRaw": 0.53,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 85.49,
    "markerNumModels": 9,
    "diseaseTerm": "Motor Neuropathy, Peripheral, With Dysautonomia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:261236",
    "phenodigmScore": 46.78,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.58,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 76.98,
    "markerNumModels": 9,
    "diseaseTerm": "16P13.11 Microdeletion Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:95619",
    "phenodigmScore": 56.095,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0040086 Abnormal prolactin level,HP:0008245 Pituitary hypothyroidism,HP:0000871 Panhypopituitarism,HP:0000863 Central diabetes insipidus,HP:0000824 Decreased response to growth hormone stimulation test,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.83,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.36,
    "markerNumModels": 9,
    "diseaseTerm": "Post-Traumatic Pituitary Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:263800",
    "phenodigmScore": 45.9,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001962 Palpitations,HP:0001657 Prolonged QT interval,HP:0002615 Hypotension,HP:0004756 Ventricular tachycardia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.49,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.31,
    "markerNumModels": 9,
    "diseaseTerm": "Gitelman Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:247200",
    "phenodigmScore": 45.9,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007045 Midline brain calcifications,HP:0002389 Cavum septum pellucidum,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0031882 Agyria,HP:0002282 Gray matter heterotopia,HP:0001339 Lissencephaly,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.25,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 73.55,
    "markerNumModels": 9,
    "diseaseTerm": "Miller-Dieker Lissencephaly Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1895",
    "phenodigmScore": 45.705,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.46,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 84.95,
    "markerNumModels": 9,
    "diseaseTerm": "Edinburgh Malformation Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:300894",
    "phenodigmScore": 56.519999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.85,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.19,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodegeneration With Brain Iron Accumulation 5",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98853",
    "phenodigmScore": 48.30500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0001639 Hypertrophic cardiomyopathy,HP:0002486 Myotonia,HP:0005155 Ventricular escape rhythm,HP:0001678 Atrioventricular block,HP:0001771 Achilles tendon contracture,HP:0004631 Decreased cervical spine flexion due to contractures of posterior cervical muscles,HP:0001387 Joint stiffness,HP:0001645 Sudden cardiac death,HP:0005115 Supraventricular arrhythmia,HP:0002987 Elbow flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 19.1,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Dominant Emery-Dreifuss Muscular Dystrophy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:88673",
    "phenodigmScore": 52.224999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001409 Portal hypertension,HP:0001894 Thrombocytosis,HP:0002639 Budd-Chiari syndrome,HP:0001901 Polycythemia,HP:0002605 Hepatic necrosis,HP:0001903 Anemia,HP:0001873 Thrombocytopenia,HP:0011029 Internal hemorrhage,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 18.79,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 85.66,
    "markerNumModels": 9,
    "diseaseTerm": "Hepatocellular Carcinoma",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98855",
    "phenodigmScore": 48.415000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0002486 Myotonia,HP:0005155 Ventricular escape rhythm,HP:0001678 Atrioventricular block,HP:0001771 Achilles tendon contracture,HP:0004631 Decreased cervical spine flexion due to contractures of posterior cervical muscles,HP:0001387 Joint stiffness,HP:0001645 Sudden cardiac death,HP:0005115 Supraventricular arrhythmia,HP:0002987 Elbow flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 19.32,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Recessive Emery-Dreifuss Muscular Dystrophy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:227510",
    "phenodigmScore": 50.69499999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0012670 Orthostatic syncope,HP:0030880 Raynaud phenomenon,HP:0005341 Autonomic bladder dysfunction,HP:0008652 Autonomic erectile dysfunction,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.93,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 82.46,
    "markerNumModels": 9,
    "diseaseTerm": "Multiple System Atrophy, Cerebellar Type",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1954",
    "phenodigmScore": 55.285000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 23.87,
    "diseaseModelAvgRaw": 0.52,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 86.7,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Lethal Erythroderma",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:604121",
    "phenodigmScore": 44.855,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 9.72,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001501 abnormal sleep pattern",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Cerebellar Ataxia, Deafness, And Narcolepsy, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:139090",
    "phenodigmScore": 52.735,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis,HP:0000421 Epistaxis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 26.17,
    "diseaseModelAvgRaw": 0.61,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Gray Platelet Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:236795",
    "phenodigmScore": 60.32,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0006906 Congenital intracerebral calcification,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 31.37,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 89.27,
    "markerNumModels": 9,
    "diseaseTerm": "3-Hydroxyisobutyric Aciduria",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:160800",
    "phenodigmScore": 56.650000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0012899 Handgrip myotonia,HP:0010548 Percussion myotonia,HP:0003730 EMG: myotonic runs,HP:0003740 Myotonia with warm-up phenomenon",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 35.79,
    "diseaseModelAvgRaw": 0.88,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonia Congenita, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:254950",
    "phenodigmScore": 48.230000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 18.95,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myopathy, Granulovacuolar Lobular, With Electrical Myotonia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:266400",
    "phenodigmScore": 50.56,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007968 Remnants of the hyaloid vascular system,HP:0007973 Retinal dysplasia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 35.1,
    "diseaseModelAvgRaw": 0.92,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.09,
    "diseaseModelMaxNorm": 66.02,
    "markerNumModels": 9,
    "diseaseTerm": "Reese Retinal Dysplasia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:247234",
    "phenodigmScore": 42.695,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001291 Abnormal cranial nerve morphology,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.05,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 77.34,
    "markerNumModels": 9,
    "diseaseTerm": "Sporadic Adult-Onset Ataxia Of Unknown Etiology",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:242840",
    "phenodigmScore": 47.074999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0010636 Schizencephaly,HP:0001638 Cardiomyopathy,HP:0001635 Congestive heart failure,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.74,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 74.41,
    "markerNumModels": 9,
    "diseaseTerm": "Vici Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:166990",
    "phenodigmScore": 62.69499999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001274 Agenesis of corpus callosum,HP:0001873 Thrombocytopenia,HP:0000238 Hydrocephalus",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 45.62,
    "diseaseModelAvgRaw": 1.02,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0009937 abnormal neuron differentiation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 1.95,
    "diseaseModelMaxNorm": 79.77,
    "markerNumModels": 9,
    "diseaseTerm": "Osteochondrodysplasia, Rhizomelic, With Callosal Agenesis, Thrombocytopenia, Hydrocephalus, And Hypertension",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615948",
    "phenodigmScore": 39.230000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007165 Periventricular heterotopia,HP:0009879 Simplified gyral pattern,HP:0000588 Optic disc coloboma,HP:0002126 Polymicrogyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.65,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 63.81,
    "markerNumModels": 9,
    "diseaseTerm": "Orofaciodigital Syndrome Xiv",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:300049",
    "phenodigmScore": 52.14,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.27,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 85.01,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Nodular Heterotopia 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:101029",
    "phenodigmScore": 75.315,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002538 Abnormal cerebral cortex morphology,HP:0002126 Polymicrogyria,HP:0032391 Subcortical heterotopia,HP:0002134 Abnormality of the basal ganglia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 54.36,
    "diseaseModelAvgRaw": 1.04,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 96.27,
    "markerNumModels": 9,
    "diseaseTerm": "Sub-Cortical Nodular Heterotopia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2512",
    "phenodigmScore": 60.584999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007333 Hypoplasia of the frontal lobes,HP:0001302 Pachygyria,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 38.79,
    "diseaseModelAvgRaw": 0.82,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 82.38,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Recessive Primary Microcephaly",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:139417",
    "phenodigmScore": 43.045,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001278 Orthostatic hypotension,HP:0005341 Autonomic bladder dysfunction,HP:0002138 Subarachnoid hemorrhage,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.21,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 74.88,
    "markerNumModels": 9,
    "diseaseTerm": "Acute Transverse Myelitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:101046",
    "phenodigmScore": 50.84,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.39,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Dominant Epilepsy With Auditory Features",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614575",
    "phenodigmScore": 44.835,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.51,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 79.16,
    "markerNumModels": 9,
    "diseaseTerm": "Cerebellar Ataxia, Neuropathy, And Vestibular Areflexia Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:219730",
    "phenodigmScore": 39.9,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.3,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 70.5,
    "markerNumModels": 9,
    "diseaseTerm": "Ventriculomegaly With Cystic Kidney Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:605039",
    "phenodigmScore": 45.185,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.09,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 78.28,
    "markerNumModels": 9,
    "diseaseTerm": "Bohring-Opitz Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615548",
    "phenodigmScore": 51.705000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.15,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.26,
    "markerNumModels": 9,
    "diseaseTerm": "Neuropathy, Hereditary Sensory And Autonomic, Type Vii",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615544",
    "phenodigmScore": 61.595,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032388 Periventricular nodular heterotopia,HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.19,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Periventricular Nodular Heterotopia 6",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:251880",
    "phenodigmScore": 47.574999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002904 Hyperbilirubinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 9.77,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.38,
    "markerNumModels": 9,
    "diseaseTerm": "Mitochondrial Dna Depletion Syndrome 3 (Hepatocerebral Type)",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79473",
    "phenodigmScore": 45.09,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001649 Tachycardia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.31,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 80.87,
    "markerNumModels": 9,
    "diseaseTerm": "Porphyria Variegata",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617822",
    "phenodigmScore": 46.725,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001339 Lissencephaly,HP:0007370 Aplasia/Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.94,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 81.51,
    "markerNumModels": 9,
    "diseaseTerm": "Alkuraya-Kucinskas Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616212",
    "phenodigmScore": 57.645,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001338 Partial agenesis of the corpus callosum,HP:0045028 Microlissencephaly,HP:0007165 Periventricular heterotopia,HP:0009879 Simplified gyral pattern,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0001339 Lissencephaly,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 37.39,
    "diseaseModelAvgRaw": 0.76,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 77.9,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly 6 With Microcephaly",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79318",
    "phenodigmScore": 36.39,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012509 Reduced thyroxin-binding globulin,HP:0030609 Photoreceptor layer loss on macular OCT,HP:0000510 Rod-cone dystrophy,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 7.32,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 65.46,
    "markerNumModels": 9,
    "diseaseTerm": "Pmm2-Cdg",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:945",
    "phenodigmScore": 50.980000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002414 Spina bifida",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.95,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0008503 abnormal spinal cord grey matter morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 86.01,
    "markerNumModels": 9,
    "diseaseTerm": "Acalvaria",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614643",
    "phenodigmScore": 51.74,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001338 Partial agenesis of the corpus callosum,HP:0000609 Optic nerve hypoplasia,HP:0001339 Lissencephaly,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0031882 Agyria,HP:0032391 Subcortical heterotopia,HP:0002282 Gray matter heterotopia,HP:0007260 Type II lissencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 30.94,
    "diseaseModelAvgRaw": 0.66,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 72.54,
    "markerNumModels": 9,
    "diseaseTerm": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Brain And Eye Anomalies), Type A, 7",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:95494",
    "phenodigmScore": 49.440000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0040086 Abnormal prolactin level,HP:0100842 Septo-optic dysplasia,HP:0000824 Decreased response to growth hormone stimulation test,HP:0008245 Pituitary hypothyroidism,HP:0000609 Optic nerve hypoplasia,HP:0001331 Absent septum pellucidum,HP:0010626 Anterior pituitary agenesis,HP:0010627 Anterior pituitary hypoplasia,HP:0040075 Hypopituitarism,HP:0012731 Ectopic anterior pituitary gland,HP:0011755 Ectopic posterior pituitary,HP:0001274 Agenesis of corpus callosum,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.59,
    "diseaseModelAvgRaw": 0.57,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 73.29,
    "markerNumModels": 9,
    "diseaseTerm": "Combined Pituitary Hormone Deficiencies, Genetic Forms",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:275872",
    "phenodigmScore": 52.065,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002366 Abnormal lower motor neuron morphology,HP:0002314 Degeneration of the lateral corticospinal tracts,HP:0002127 Abnormal upper motor neuron morphology,HP:0007190 Neuronal loss in the cerebral cortex",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.03,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 82.1,
    "markerNumModels": 9,
    "diseaseTerm": "Frontotemporal Dementia With Motor Neuron Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616000",
    "phenodigmScore": 58.57,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003141 Increased LDL cholesterol concentration,HP:0003124 Hypercholesterolemia,HP:0032386 Elevated circulating transferrin concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 27.34,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 89.8,
    "markerNumModels": 9,
    "diseaseTerm": "Analbuminemia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618974",
    "phenodigmScore": 49.315,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002079 Hypoplasia of the corpus callosum,HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.99,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 82.64,
    "markerNumModels": 9,
    "diseaseTerm": "Li-Ghorbani-Weisz-Hubshman Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:614",
    "phenodigmScore": 48.445,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 19.38,
    "diseaseModelAvgRaw": 0.56,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Thomsen And Becker Disease",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98292",
    "phenodigmScore": 47.31,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002239 Gastrointestinal hemorrhage,HP:0011675 Arrhythmia,HP:0100585 Telangiectasia of the skin,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.03,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.59,
    "markerNumModels": 9,
    "diseaseTerm": "Mastocytosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:613870",
    "phenodigmScore": 51.305,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0002251 Aganglionic megacolon,HP:0001649 Tachycardia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.09,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 84.52,
    "markerNumModels": 9,
    "diseaseTerm": "Hirschsprung Disease, Cardiac Defects, And Autonomic Dysfunction",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:305390",
    "phenodigmScore": 54.410000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011532 Subretinal exudate,HP:0030490 Exudative vitreoretinopathy,HP:0011530 Retinal hole,HP:0007710 Peripheral vitreous opacities,HP:0000541 Retinal detachment,HP:0030666 Retinal neovascularization,HP:0012841 Retinal vascular tortuosity,HP:0007989 Intraretinal exudate,HP:0001493 Falciform retinal fold",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 41.81,
    "diseaseModelAvgRaw": 0.93,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.01,
    "diseaseModelMaxNorm": 67.01,
    "markerNumModels": 9,
    "diseaseTerm": "Exudative Vitreoretinopathy 2, X-Linked",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:311200",
    "phenodigmScore": 46.525,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0000822 Hypertension,HP:0002475 Myelomeningocele,HP:0002444 Hypothalamic hamartoma,HP:0002132 Porencephalic cyst,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.33,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 73.72,
    "markerNumModels": 9,
    "diseaseTerm": "Orofaciodigital Syndrome I",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618709",
    "phenodigmScore": 64.705,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002539 Cortical dysplasia,HP:0001273 Abnormal corpus callosum morphology,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.91,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 99.5,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder With Nonspecific Brain Abnormalities And With Or Without Seizures",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614034",
    "phenodigmScore": 60.24,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001894 Thrombocytosis,HP:0001746 Asplenia,HP:0004844 Coombs-positive hemolytic anemia,HP:0000421 Epistaxis,HP:0025420 Diffuse alveolar hemorrhage,HP:0001878 Hemolytic anemia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 24.81,
    "diseaseModelAvgRaw": 0.56,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 95.67,
    "markerNumModels": 9,
    "diseaseTerm": "Heme Oxygenase 1 Deficiency",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:358",
    "phenodigmScore": 45.095,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0025072 Prominent U wave,HP:0001279 Syncope,HP:0005135 Abnormal T-wave,HP:0001657 Prolonged QT interval,HP:0001962 Palpitations,HP:0012250 ST segment depression,HP:0002632 Low-to-normal blood pressure,HP:0030880 Raynaud phenomenon,HP:0002514 Cerebral calcification,HP:0012248 Prolonged PR interval,HP:0001663 Ventricular fibrillation",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.11,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.53,
    "diseaseModelMaxNorm": 78.08,
    "markerNumModels": 9,
    "diseaseTerm": "Gitelman Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2131",
    "phenodigmScore": 42.965,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0005135 Abnormal T-wave,HP:0031546 Cardiac conduction abnormality,HP:0001638 Cardiomyopathy,HP:0011675 Arrhythmia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.67,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.26,
    "markerNumModels": 9,
    "diseaseTerm": "Alternating Hemiplegia Of Childhood",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:231095",
    "phenodigmScore": 55.97,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0005890 Hyperostosis cranialis interna,HP:0011974 Myelofibrosis,HP:0011001 Increased bone mineral density",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 32.64,
    "diseaseModelAvgRaw": 0.79,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Ghosal Hematodiaphyseal Dysplasia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3452",
    "phenodigmScore": 48.57,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0001701 Pericarditis,HP:0001658 Myocardial infarction,HP:0002239 Gastrointestinal hemorrhage,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.95,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.19,
    "markerNumModels": 9,
    "diseaseTerm": "Whipple Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "DECIPHER:31",
    "phenodigmScore": 58.27,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012078 Motor conduction block,HP:0002450 Abnormal motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 26.51,
    "diseaseModelAvgRaw": 0.68,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.34,
    "diseaseModelMaxNorm": 90.03,
    "markerNumModels": 9,
    "diseaseTerm": "Hereditary Liability to Pressure Palsies (HNPP)",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:97355",
    "phenodigmScore": 61.33,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007045 Midline brain calcifications,HP:0012753 T2 hypointense basal ganglia,HP:0001278 Orthostatic hypotension,HP:0005341 Autonomic bladder dysfunction,HP:0002120 Cerebral cortical atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 31.47,
    "diseaseModelAvgRaw": 0.64,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.19,
    "markerNumModels": 9,
    "diseaseTerm": "Caribbean Parkinsonism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:36234",
    "phenodigmScore": 47.055,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0031273 Shock,HP:0001649 Tachycardia,HP:0002615 Hypotension,HP:0030005 Capillary leak",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.63,
    "diseaseModelAvgRaw": 0.15,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.48,
    "markerNumModels": 9,
    "diseaseTerm": "Bacterial Toxic-Shock Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:223300",
    "phenodigmScore": 46.86,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.73,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001501 abnormal sleep pattern",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Disseminated Sclerosis With Narcolepsy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:85138",
    "phenodigmScore": 43.974999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.1,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.85,
    "markerNumModels": 9,
    "diseaseTerm": "Addison Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:244242",
    "phenodigmScore": 44.695,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001342 Cerebral hemorrhage,HP:0011029 Internal hemorrhage,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.17,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.22,
    "markerNumModels": 9,
    "diseaseTerm": "Hellp Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619381",
    "phenodigmScore": 39.07,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011227 Elevated circulating C-reactive protein concentration,HP:0003228 Hypernatremia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 7.69,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 70.45,
    "markerNumModels": 9,
    "diseaseTerm": "Immunodeficiency 82 With Systemic Inflammation",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:319213",
    "phenodigmScore": 48.7,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0031273 Shock,HP:0011896 Subconjunctival hemorrhage,HP:0001662 Bradycardia,HP:0002181 Cerebral edema,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.07,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.33,
    "markerNumModels": 9,
    "diseaseTerm": "Lujo Hemorrhagic Fever",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614483",
    "phenodigmScore": 59.925,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002170 Intracranial hemorrhage,HP:0010636 Schizencephaly,HP:0002132 Porencephalic cyst,HP:0002126 Polymicrogyria,HP:0032391 Subcortical heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 37.21,
    "diseaseModelAvgRaw": 0.77,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 82.64,
    "markerNumModels": 9,
    "diseaseTerm": "Brain Small Vessel Disease 2",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:439822",
    "phenodigmScore": 49.235,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 3.81,
    "diseaseModelAvgRaw": 0.08,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 94.66,
    "markerNumModels": 9,
    "diseaseTerm": "Pde4D Haploinsufficiency Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90062",
    "phenodigmScore": 44.56,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0002170 Intracranial hemorrhage,HP:0002239 Gastrointestinal hemorrhage,HP:0002181 Cerebral edema,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.48,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 77.64,
    "markerNumModels": 9,
    "diseaseTerm": "Acute Liver Failure",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:606",
    "phenodigmScore": 48.655,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 19.8,
    "diseaseModelAvgRaw": 0.5,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Proximal Myotonic Myopathy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90794",
    "phenodigmScore": 41.36,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011106 Hypovolemia,HP:0031273 Shock,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 5.08,
    "diseaseModelAvgRaw": 0.12,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 77.64,
    "markerNumModels": 9,
    "diseaseTerm": "Classic Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614250",
    "phenodigmScore": 46.095,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0030050 Narcolepsy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 12.2,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001501 abnormal sleep pattern",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Narcolepsy 7",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90068",
    "phenodigmScore": 47.925,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001342 Cerebral hemorrhage,HP:0000822 Hypertension,HP:0001657 Prolonged QT interval,HP:0004308 Ventricular arrhythmia,HP:0001649 Tachycardia,HP:0001658 Myocardial infarction,HP:0011106 Hypovolemia,HP:0002138 Subarachnoid hemorrhage,HP:0002140 Ischemic stroke,HP:0025420 Diffuse alveolar hemorrhage,HP:0006677 Prolonged QRS complex,HP:0005115 Supraventricular arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.78,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.07,
    "markerNumModels": 9,
    "diseaseTerm": "Cocaine Intoxication",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2152",
    "phenodigmScore": 36.76,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002251 Aganglionic megacolon,HP:0007048 Large basal ganglia,HP:0007165 Periventricular heterotopia,HP:0001642 Pulmonic stenosis,HP:0007042 Focal white matter lesions,HP:0002126 Polymicrogyria,HP:0001650 Aortic valve stenosis,HP:0002500 Abnormal cerebral white matter morphology,HP:0032046 Focal cortical dysplasia,HP:0002079 Hypoplasia of the corpus callosum,HP:0025100 Abnormal hippocampus morphology,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.7,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 63.82,
    "markerNumModels": 9,
    "diseaseTerm": "Mowat-Wilson Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3299",
    "phenodigmScore": 49.935,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001662 Bradycardia,HP:0001649 Tachycardia,HP:0005341 Autonomic bladder dysfunction,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.23,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 82.64,
    "markerNumModels": 9,
    "diseaseTerm": "Tetanus",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:602579",
    "phenodigmScore": 50.589999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 13.66,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 87.52,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Disorder Of Glycosylation, Type Ib",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:434179",
    "phenodigmScore": 40.275,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007082 Dilated third ventricle,HP:0001338 Partial agenesis of the corpus callosum,HP:0007165 Periventricular heterotopia,HP:0100954 Open operculum,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.74,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 63.81,
    "markerNumModels": 9,
    "diseaseTerm": "Orofaciodigital Syndrome Type 14",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99803",
    "phenodigmScore": 44.595,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002251 Aganglionic megacolon,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.23,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.96,
    "markerNumModels": 9,
    "diseaseTerm": "Haddad Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618963",
    "phenodigmScore": 60.05,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0001876 Pancytopenia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 20.1,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Immunodeficiency 69",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:75857",
    "phenodigmScore": 46.21,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002538 Abnormal cerebral cortex morphology,HP:0030048 Colpocephaly,HP:0007165 Periventricular heterotopia,HP:0002126 Polymicrogyria,HP:0002500 Abnormal cerebral white matter morphology,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.76,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 70.66,
    "markerNumModels": 9,
    "diseaseTerm": "6Q Terminal Deletion Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615960",
    "phenodigmScore": 51.315000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002518 Abnormal periventricular white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.12,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 81.51,
    "markerNumModels": 9,
    "diseaseTerm": "Poretti-Boltshauser Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615510",
    "phenodigmScore": 45.65,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.49,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 75.81,
    "markerNumModels": 9,
    "diseaseTerm": "Alacrima, Achalasia, And Mental Retardation Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:101030",
    "phenodigmScore": 60.18,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002435 Meningocele,HP:0001338 Partial agenesis of the corpus callosum,HP:0002269 Abnormality of neuronal migration,HP:0002475 Myelomeningocele,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0032046 Focal cortical dysplasia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 39.97,
    "diseaseModelAvgRaw": 0.84,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 80.39,
    "markerNumModels": 9,
    "diseaseTerm": "Subependymal Nodular Heterotopia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618329",
    "phenodigmScore": 47.81,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0003348 Hyperalaninemia,HP:0040031 Chorioretinal hyperpigmentation,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.07,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 80.55,
    "markerNumModels": 9,
    "diseaseTerm": "Combined Oxidative Phosphorylation Deficiency 37",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607250",
    "phenodigmScore": 58.900000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003124 Hypercholesterolemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 26.26,
    "diseaseModelAvgRaw": 0.52,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Spinocerebellar Ataxia, Autosomal Recessive, With Axonal Neuropathy 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614373",
    "phenodigmScore": 54.47,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology,HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 27.43,
    "diseaseModelAvgRaw": 0.62,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 81.51,
    "markerNumModels": 9,
    "diseaseTerm": "Amyotrophic Lateral Sclerosis 16, Juvenile",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618870",
    "phenodigmScore": 45.135,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0005180 Tricuspid regurgitation,HP:0001331 Absent septum pellucidum,HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.58,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 77.69,
    "markerNumModels": 9,
    "diseaseTerm": "Skeletal Dysplasia, Mild, With Joint Laxity And Advanced Bone Age",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:94093",
    "phenodigmScore": 53.695,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0100735 Hypertensive crisis,HP:0001649 Tachycardia,HP:0001662 Bradycardia,HP:0002204 Pulmonary embolism,HP:0001873 Thrombocytopenia,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 17.74,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 89.65,
    "markerNumModels": 9,
    "diseaseTerm": "Neuroleptic Malignant Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:170500",
    "phenodigmScore": 45.825,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 16.28,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 75.37,
    "markerNumModels": 9,
    "diseaseTerm": "Hyperkalemic Periodic Paralysis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:261250",
    "phenodigmScore": 46.19,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0001653 Mitral regurgitation,HP:0007165 Periventricular heterotopia,HP:0030048 Colpocephaly,HP:0000609 Optic nerve hypoplasia,HP:0002079 Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.52,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 74.86,
    "markerNumModels": 9,
    "diseaseTerm": "16Q24.3 Microdeletion Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:280071",
    "phenodigmScore": 47.19499999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012762 Cerebral white matter atrophy,HP:0002500 Abnormal cerebral white matter morphology,HP:0002282 Gray matter heterotopia,HP:0002059 Cerebral atrophy,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.9,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 77.49,
    "markerNumModels": 9,
    "diseaseTerm": "Alg11-Cdg",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:567548",
    "phenodigmScore": 49.775,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003119 Abnormal circulating lipid concentration,HP:0003124 Hypercholesterolemia,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 16.81,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 82.74,
    "markerNumModels": 9,
    "diseaseTerm": "Idiopathic Steroid-Resistant Nephrotic Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:449285",
    "phenodigmScore": 55.825,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002170 Intracranial hemorrhage,HP:0000421 Epistaxis,HP:0001649 Tachycardia,HP:0002637 Cerebral ischemia,HP:0030149 Cardiogenic shock,HP:0001658 Myocardial infarction,HP:0040075 Hypopituitarism,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.26,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 92.39,
    "markerNumModels": 9,
    "diseaseTerm": "Snakebite Envenomation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:261318",
    "phenodigmScore": 44.575,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002414 Spina bifida,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.82,
    "diseaseModelAvgRaw": 0.1,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 84.33,
    "markerNumModels": 9,
    "diseaseTerm": "Trisomy 20P",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1051",
    "phenodigmScore": 44.405,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0002251 Aganglionic megacolon,HP:0011451 Primary microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.56,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.25,
    "markerNumModels": 9,
    "diseaseTerm": "Ramos-Arroyo Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:398063",
    "phenodigmScore": 54.38,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003073 Hypoalbuminemia,HP:0002148 Hypophosphatemia,HP:0002917 Hypomagnesemia,HP:0002901 Hypocalcemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 18.72,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 90.04,
    "markerNumModels": 9,
    "diseaseTerm": "Refractory Celiac Disease",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:91347",
    "phenodigmScore": 48.465,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0012505 Enlarged pituitary gland,HP:0004308 Ventricular arrhythmia,HP:0001962 Palpitations,HP:0008240 Secondary growth hormone deficiency,HP:0012503 Abnormality of the pituitary gland,HP:0000837 Increased circulating gonadotropin level,HP:0002925 Elevated circulating thyroid-stimulating hormone concentration,HP:0001635 Congestive heart failure,HP:0011748 Adrenocorticotropic hormone deficiency,HP:0000845 Elevated circulating growth hormone concentration,HP:0002615 Hypotension,HP:0005115 Supraventricular arrhythmia,HP:0000870 Increased circulating prolactin concentration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.75,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 82.18,
    "markerNumModels": 9,
    "diseaseTerm": "Tsh-Secreting Pituitary Adenoma",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:187600",
    "phenodigmScore": 43.09,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.53,
    "diseaseModelAvgRaw": 0.14,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 79.65,
    "markerNumModels": 9,
    "diseaseTerm": "Thanatophoric Dysplasia, Type I",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2828",
    "phenodigmScore": 42.800000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 5.87,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 79.73,
    "markerNumModels": 9,
    "diseaseTerm": "Young-Onset Parkinson Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615491",
    "phenodigmScore": 44.61,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0001371 Flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 11.71,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Spastic Paraplegia 79, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615191",
    "phenodigmScore": 61.69,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0032409 Subcortical band heterotopia,HP:0002352 Leukoencephalopathy,HP:0002079 Hypoplasia of the corpus callosum,HP:0002132 Porencephalic cyst,HP:0002500 Abnormal cerebral white matter morphology,HP:0002282 Gray matter heterotopia,HP:0007260 Type II lissencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 38.33,
    "diseaseModelAvgRaw": 0.74,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 85.05,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly 5",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1852",
    "phenodigmScore": 59.224999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008046 Abnormal retinal vascular morphology,HP:0007703 Abnormality of retinal pigmentation,HP:0007973 Retinal dysplasia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 35.54,
    "diseaseModelAvgRaw": 0.73,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.09,
    "diseaseModelMaxNorm": 82.91,
    "markerNumModels": 9,
    "diseaseTerm": "X-Linked Retinal Dysplasia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:95409",
    "phenodigmScore": 46.419999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0001658 Myocardial infarction,HP:0002615 Hypotension,HP:0011106 Hypovolemia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.77,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.07,
    "markerNumModels": 9,
    "diseaseTerm": "Acute Adrenal Insufficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79076",
    "phenodigmScore": 41.925000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 7.34,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 76.51,
    "markerNumModels": 9,
    "diseaseTerm": "Juvenile Polyposis Of Infancy",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614298",
    "phenodigmScore": 43.135000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002366 Abnormal lower motor neuron morphology,HP:0000648 Optic atrophy,HP:0100315 Lewy bodies",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.96,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 67.31,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodegeneration With Brain Iron Accumulation 4",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:199299",
    "phenodigmScore": 49.44,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002893 Pituitary adenoma,HP:0002615 Hypotension,HP:0001278 Orthostatic hypotension,HP:0011748 Adrenocorticotropic hormone deficiency",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.56,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.32,
    "markerNumModels": 9,
    "diseaseTerm": "Late-Onset Isolated Acth Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2481",
    "phenodigmScore": 47.68,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002435 Meningocele,HP:0002269 Abnormality of neuronal migration,HP:0002170 Intracranial hemorrhage,HP:0003396 Syringomyelia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.92,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension,MP:0008503 abnormal spinal cord grey matter morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 78.44,
    "markerNumModels": 9,
    "diseaseTerm": "Neurocutaneous Melanocytosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2912",
    "phenodigmScore": 49.46,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0031274 Hypovolemic shock,HP:0040131 Abnormal motor nerve conduction velocity,HP:0012486 Myelitis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.41,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 86.51,
    "markerNumModels": 9,
    "diseaseTerm": "Poliomyelitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1860",
    "phenodigmScore": 41.3,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.38,
    "diseaseModelAvgRaw": 0.1,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 78.22,
    "markerNumModels": 9,
    "diseaseTerm": "Thanatophoric Dysplasia Type 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:33475",
    "phenodigmScore": 49.915,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0001085 Papilledema,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.03,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.8,
    "markerNumModels": 9,
    "diseaseTerm": "Meningococcal Meningitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90363",
    "phenodigmScore": 43.849999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032387 Reduced circulating transferrin concentration,HP:0031085 Decreased prealbumin level,HP:0003146 Hypocholesterolemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 11.54,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 76.16,
    "markerNumModels": 9,
    "diseaseTerm": "Secondary Intestinal Lymphangiectasia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:603553",
    "phenodigmScore": 52.245,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0003075 Hypoproteinemia,HP:0003573 Increased total bilirubin,HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.77,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 88.72,
    "markerNumModels": 9,
    "diseaseTerm": "Hemophagocytic Lymphohistiocytosis, Familial, 2",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "DECIPHER:59",
    "phenodigmScore": 52.605,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.49,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 89.72,
    "markerNumModels": 9,
    "diseaseTerm": "Adult-onset autosomal dominant leukodystrophy (ADLD)",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:300573",
    "phenodigmScore": 64.945,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012650 Perisylvian polymicrogyria,HP:0010636 Schizencephaly,HP:0025102 Dysgenesis of the basal ganglia,HP:0002339 Abnormal caudate nucleus morphology,HP:0001273 Abnormal corpus callosum morphology,HP:0002389 Cavum septum pellucidum,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0006956 Dilation of lateral ventricles,HP:0001339 Lissencephaly,HP:0002539 Cortical dysplasia,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 46.32,
    "diseaseModelAvgRaw": 0.93,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 83.57,
    "markerNumModels": 9,
    "diseaseTerm": "Polymicrogyria Due To Tubb2B Mutation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:529808",
    "phenodigmScore": 48.29,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia,HP:0003228 Hypernatremia,HP:0003265 Neonatal hyperbilirubinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 16.87,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.71,
    "markerNumModels": 9,
    "diseaseTerm": "Chronic Bilirubin Encephalopathy",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:146500",
    "phenodigmScore": 43.665,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.17,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 74.16,
    "markerNumModels": 9,
    "diseaseTerm": "Multiple System Atrophy 1, Susceptibility To",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79324",
    "phenodigmScore": 45.285,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003146 Hypocholesterolemia,HP:0002902 Hyponatremia,HP:0000541 Retinal detachment,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 6.99,
    "diseaseModelAvgRaw": 0.15,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.58,
    "markerNumModels": 9,
    "diseaseTerm": "Alg12-Cdg",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:31826",
    "phenodigmScore": 50.925,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0000822 Hypertension,HP:0001657 Prolonged QT interval,HP:0005110 Atrial fibrillation,HP:0010628 Facial palsy,HP:0001649 Tachycardia,HP:0002181 Cerebral edema,HP:0001635 Congestive heart failure,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.38,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.47,
    "markerNumModels": 9,
    "diseaseTerm": "Ethylene Glycol Poisoning",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:235255",
    "phenodigmScore": 49.620000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0002901 Hypocalcemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.12,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Mullerian Derivatives, Persistence Of, With Lymphangiectasia And Postaxial Polydactyly",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618960",
    "phenodigmScore": 61.715,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0002500 Abnormal cerebral white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 32.14,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Mitchell Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:601977",
    "phenodigmScore": 58.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 17.78,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Thrombocythemia 2",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:54370",
    "phenodigmScore": 58.80500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia,HP:0011510 Drusen",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 26.07,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Membranoproliferative Glomerulonephritis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608643",
    "phenodigmScore": 45.459999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 5.57,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.35,
    "markerNumModels": 9,
    "diseaseTerm": "Aromatic L-Amino Acid Decarboxylase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:453504",
    "phenodigmScore": 41.315,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000609 Optic nerve hypoplasia,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.91,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 73.72,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder-Craniofacial Dysmorphism-Cardiac Defect-Skeletal Anomalies Syndrome Due To A Point Mutation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99827",
    "phenodigmScore": 46.07,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0000822 Hypertension,HP:0000573 Retinal hemorrhage,HP:0100309 Subdural hemorrhage,HP:0011896 Subconjunctival hemorrhage,HP:0002615 Hypotension,HP:0000421 Epistaxis,HP:0002092 Pulmonary arterial hypertension,HP:0001649 Tachycardia,HP:0002249 Melena,HP:0002248 Hematemesis,HP:0001662 Bradycardia,HP:0011710 Bundle branch block,HP:0011854 Hemoperitoneum,HP:0025420 Diffuse alveolar hemorrhage,HP:0005162 Abnormal left ventricular function,HP:0012151 Hemothorax,HP:0011029 Internal hemorrhage,HP:0030005 Capillary leak",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.08,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.06,
    "markerNumModels": 9,
    "diseaseTerm": "Crimean-Congo Hemorrhagic Fever",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:264350",
    "phenodigmScore": 49.019999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.55,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 88.49,
    "markerNumModels": 9,
    "diseaseTerm": "Pseudohypoaldosteronism, Type I, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615546",
    "phenodigmScore": 44.07000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0032409 Subcortical band heterotopia,HP:0032388 Periventricular nodular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.71,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 76.43,
    "markerNumModels": 9,
    "diseaseTerm": "Van Maldergem Syndrome 2",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:67",
    "phenodigmScore": 45.040000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.57,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.51,
    "markerNumModels": 9,
    "diseaseTerm": "Amoebiasis Due To Entamoeba Histolytica",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2318",
    "phenodigmScore": 47.195,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0002251 Aganglionic megacolon,HP:0007370 Aplasia/Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.48,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 78.91,
    "markerNumModels": 9,
    "diseaseTerm": "Joubert Syndrome With Oculorenal Defect",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100082",
    "phenodigmScore": 49.440000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0007380 Facial telangiectasia,HP:0001962 Palpitations,HP:0005180 Tricuspid regurgitation,HP:0002249 Melena,HP:0002615 Hypotension,HP:0002573 Hematochezia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.4,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 84.48,
    "markerNumModels": 9,
    "diseaseTerm": "Neuroendocrine Tumor Of Anal Canal",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617903",
    "phenodigmScore": 49.06999999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.9,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.24,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder With Poor Language And Loss Of Hand Skills",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:163921",
    "phenodigmScore": 52.935,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0025100 Abnormal hippocampus morphology,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.34,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 85.53,
    "markerNumModels": 9,
    "diseaseTerm": "Posttransplant Acute Limbic Encephalitis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:247598",
    "phenodigmScore": 50.24,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010903 Abnormal circulating glutamine concentration,HP:0012278 Abnormal circulating serine concentration,HP:0010916 Abnormal circulating alanine concentration,HP:0003233 Decreased HDL cholesterol concentration,HP:0012024 Hypergalactosemia,HP:0002161 Hyperlysinemia,HP:0003141 Increased LDL cholesterol concentration,HP:0003119 Abnormal circulating lipid concentration,HP:0003231 Hypertyrosinemia,HP:0002904 Hyperbilirubinemia,HP:0001987 Hyperammonemia,HP:0003124 Hypercholesterolemia,HP:0003354 Hyperthreoninemia,HP:0006254 Elevated alpha-fetoprotein,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia,HP:0011966 Elevated plasma citrulline,HP:0010909 Abnormal circulating arginine concentration,HP:0003235 Hypermethioninemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 26.0,
    "diseaseModelAvgRaw": 0.6,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 74.48,
    "markerNumModels": 9,
    "diseaseTerm": "Neonatal Intrahepatic Cholestasis Due To Citrin Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:271400",
    "phenodigmScore": 57.065,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0032550 Howell-Jolly bodies,HP:0001746 Asplenia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 18.46,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 95.67,
    "markerNumModels": 9,
    "diseaseTerm": "Asplenia, Isolated Congenital",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608840",
    "phenodigmScore": 55.760000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001302 Pachygyria,HP:0002518 Abnormal periventricular white matter morphology,HP:0010628 Facial palsy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 24.18,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 87.34,
    "markerNumModels": 9,
    "diseaseTerm": "Muscular Dystrophy-Dystroglycanopathy (Congenital With Impaired Intellectual Development), Type B, 6",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:186",
    "phenodigmScore": 44.81,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003119 Abnormal circulating lipid concentration,HP:0002908 Conjugated hyperbilirubinemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.57,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.05,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Biliary Cholangitis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607225",
    "phenodigmScore": 48.584999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002492 Morphological abnormality of the corticospinal tract,HP:0002366 Abnormal lower motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.1,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0008221 abnormal hippocampal commissure morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 78.07,
    "markerNumModels": 9,
    "diseaseTerm": "Spastic Paralysis, Infantile-Onset Ascending",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1655",
    "phenodigmScore": 48.215,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0002901 Hypocalcemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 8.12,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 88.31,
    "markerNumModels": 9,
    "diseaseTerm": "M√ºllerian Derivatives-Lymphangiectasia-Polydactyly Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:52430",
    "phenodigmScore": 52.535000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002450 Abnormal motor neuron morphology,HP:0012083 Ubiquitin-positive cerebral inclusion bodies,HP:0001293 Cranial nerve compression,HP:0007354 Amyotrophic lateral sclerosis,HP:0001638 Cardiomyopathy,HP:0001635 Congestive heart failure",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.23,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.34,
    "diseaseModelMaxNorm": 84.84,
    "markerNumModels": 9,
    "diseaseTerm": "Inclusion Body Myopathy With Paget Disease Of Bone And Frontotemporal Dementia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:158061",
    "phenodigmScore": 49.345,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003281 Increased circulating ferritin concentration,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.58,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.11,
    "markerNumModels": 9,
    "diseaseTerm": "Macrophage Activation Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:604317",
    "phenodigmScore": 74.46000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0010636 Schizencephaly,HP:0001273 Abnormal corpus callosum morphology,HP:0009879 Simplified gyral pattern,HP:0001302 Pachygyria,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0001339 Lissencephaly,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 48.92,
    "diseaseModelAvgRaw": 0.92,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Microcephaly 2, Primary, Autosomal Recessive, With Or Without Cortical Malformations",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:168600",
    "phenodigmScore": 49.004999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011960 Substantia nigra gliosis,HP:0100315 Lewy bodies,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.91,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 76.1,
    "markerNumModels": 9,
    "diseaseTerm": "Parkinson Disease, Late-Onset",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:478029",
    "phenodigmScore": 46.96,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0001138 Optic neuropathy,HP:0011451 Primary microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.05,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 76.87,
    "markerNumModels": 9,
    "diseaseTerm": "Combined Oxidative Phosphorylation Defect Type 29",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:300067",
    "phenodigmScore": 69.995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001302 Pachygyria,HP:0031882 Agyria,HP:0002282 Gray matter heterotopia,HP:0001339 Lissencephaly,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 46.29,
    "diseaseModelAvgRaw": 0.91,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 93.7,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly, X-Linked, 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100070",
    "phenodigmScore": 52.935,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006892 Frontotemporal cerebral atrophy,HP:0007112 Temporal cortical atrophy,HP:0002366 Abnormal lower motor neuron morphology,HP:0002500 Abnormal cerebral white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 28.11,
    "diseaseModelAvgRaw": 0.54,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 77.76,
    "markerNumModels": 9,
    "diseaseTerm": "Progressive Non-Fluent Aphasia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:314404",
    "phenodigmScore": 46.709999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007082 Dilated third ventricle,HP:0030050 Narcolepsy,HP:0002500 Abnormal cerebral white matter morphology,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.43,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0001501 abnormal sleep pattern,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 79.99,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Dominant Cerebellar Ataxia-Deafness-Narcolepsy Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:611489",
    "phenodigmScore": 52.53,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.28,
    "diseaseModelAvgRaw": 0.51,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.78,
    "markerNumModels": 9,
    "diseaseTerm": "Corticosteroid-Binding Globulin Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:105500",
    "phenodigmScore": 49.485,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007354 Amyotrophic lateral sclerosis,HP:0002366 Abnormal lower motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.42,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 78.55,
    "markerNumModels": 9,
    "diseaseTerm": "Amyotrophic Lateral Sclerosis-Parkinsonism/Dementia Complex 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617575",
    "phenodigmScore": 48.92,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 12.58,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.26,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 14",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:466934",
    "phenodigmScore": 53.510000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0007204 Diffuse white matter abnormalities,HP:0002518 Abnormal periventricular white matter morphology,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.76,
    "diseaseModelAvgRaw": 0.53,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 81.26,
    "markerNumModels": 9,
    "diseaseTerm": "Vps11-Related Autosomal Recessive Hypomyelinating Leukodystrophy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:91547",
    "phenodigmScore": 48.675000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001882 Leukopenia,HP:0000421 Epistaxis,HP:0001903 Anemia,HP:0001649 Tachycardia,HP:0011897 Neutrophilia,HP:0001873 Thrombocytopenia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 23.37,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.21,
    "diseaseModelMaxNorm": 73.98,
    "markerNumModels": 9,
    "diseaseTerm": "Relapsing Fever",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619040",
    "phenodigmScore": 52.415000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006466 Ankle flexion contracture,HP:0010548 Percussion myotonia,HP:0025075 Increased QRS voltage,HP:0005184 Prolonged QTc interval,HP:0006380 Knee flexion contracture,HP:0012785 Flexion contracture of finger,HP:0002987 Elbow flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 26.29,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 78.54,
    "markerNumModels": 9,
    "diseaseTerm": "Myofibrillar Myopathy 10",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:304050",
    "phenodigmScore": 46.730000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007082 Dilated third ventricle,HP:0001338 Partial agenesis of the corpus callosum,HP:0000648 Optic atrophy,HP:0000588 Optic disc coloboma,HP:0002389 Cavum septum pellucidum,HP:0001302 Pachygyria,HP:0002414 Spina bifida,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0006956 Dilation of lateral ventricles,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.9,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 71.56,
    "markerNumModels": 9,
    "diseaseTerm": "Aicardi Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:610725",
    "phenodigmScore": 55.21,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 25.16,
    "diseaseModelAvgRaw": 0.61,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.26,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 3",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:243000",
    "phenodigmScore": 45.535000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.84,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 80.23,
    "markerNumModels": 9,
    "diseaseTerm": "Indifference To Pain, Congenital, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3463",
    "phenodigmScore": 45.55500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0001638 Cardiomyopathy,HP:0002239 Gastrointestinal hemorrhage,HP:0002120 Cerebral cortical atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.96,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 74.15,
    "markerNumModels": 9,
    "diseaseTerm": "Wolfram Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:247585",
    "phenodigmScore": 55.625,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0003233 Decreased HDL cholesterol concentration,HP:0003077 Hyperlipidemia,HP:0001337 Tremor,HP:0003124 Hypercholesterolemia,HP:0008281 Acute hyperammonemia,HP:0002155 Hypertriglyceridemia,HP:0003073 Hypoalbuminemia,HP:0011966 Elevated plasma citrulline",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 21.68,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001513 limb grasping,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 89.57,
    "markerNumModels": 9,
    "diseaseTerm": "Citrullinemia Type Ii",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615863",
    "phenodigmScore": 60.74,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003124 Hypercholesterolemia,HP:0003077 Hyperlipidemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 30.94,
    "diseaseModelAvgRaw": 0.75,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 90.54,
    "markerNumModels": 9,
    "diseaseTerm": "Diarrhea 7, Protein-Losing Enteropathy Type",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:178509",
    "phenodigmScore": 51.675,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.32,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 91.03,
    "markerNumModels": 9,
    "diseaseTerm": "Perry Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:20",
    "phenodigmScore": 55.675,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0002352 Leukoencephalopathy,HP:0001695 Cardiac arrest,HP:0002615 Hypotension,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 19.35,
    "diseaseModelAvgRaw": 0.44,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 92.0,
    "markerNumModels": 9,
    "diseaseTerm": "3-Hydroxy-3-Methylglutaric Aciduria",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615412",
    "phenodigmScore": 75.42,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032409 Subcortical band heterotopia,HP:0001302 Pachygyria,HP:0031882 Agyria,HP:0002282 Gray matter heterotopia,HP:0002539 Cortical dysplasia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 50.84,
    "diseaseModelAvgRaw": 0.98,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Cortical Dysplasia, Complex, With Other Brain Malformations 4",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:603554",
    "phenodigmScore": 52.125,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 13.13,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Omenn Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:608390",
    "phenodigmScore": 44.885000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 13.9,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 75.87,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonia, Potassium-Aggravated",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:247257",
    "phenodigmScore": 47.975,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011029 Internal hemorrhage,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 12.62,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 83.33,
    "markerNumModels": 9,
    "diseaseTerm": "Inhalational Anthrax",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2204",
    "phenodigmScore": 53.785,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.6,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 87.97,
    "markerNumModels": 9,
    "diseaseTerm": "Dysplastic Cortical Hyperostosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:613724",
    "phenodigmScore": 56.480000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002352 Leukoencephalopathy,HP:0002450 Abnormal motor neuron morphology,HP:0010663 Abnormality of thalamus morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 30.48,
    "diseaseModelAvgRaw": 0.68,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.34,
    "diseaseModelMaxNorm": 82.48,
    "markerNumModels": 9,
    "diseaseTerm": "Leukoencephalopathy With Dystonia And Motor Neuropathy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:531151",
    "phenodigmScore": 49.415,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0003396 Syringomyelia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.48,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 76.35,
    "markerNumModels": 9,
    "diseaseTerm": "9Q21.13 Microdeletion Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79455",
    "phenodigmScore": 51.65,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007583 Telangiectasia macularis eruptiva perstans,HP:0100585 Telangiectasia of the skin,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.84,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 94.46,
    "markerNumModels": 9,
    "diseaseTerm": "Cutaneous Mastocytoma",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:601559",
    "phenodigmScore": 45.795,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0005830 Flexion contracture of toe,HP:0000935 Thickened cortex of long bones,HP:0002092 Pulmonary arterial hypertension,HP:0000939 Osteoporosis,HP:0006380 Knee flexion contracture,HP:0002756 Pathologic fracture,HP:0009185 Contracture of the proximal interphalangeal joint of the 5th finger,HP:0002987 Elbow flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 15.08,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 76.51,
    "markerNumModels": 9,
    "diseaseTerm": "Stuve-Wiedemann Syndrome 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618049",
    "phenodigmScore": 45.779999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.1,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 82.46,
    "markerNumModels": 9,
    "diseaseTerm": "Parkinsonism-Dystonia 2, Infantile-Onset",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:369873",
    "phenodigmScore": 60.395,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension,HP:0005307 Postural hypotension with compensatory tachycardia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 24.42,
    "diseaseModelAvgRaw": 0.58,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 96.37,
    "markerNumModels": 9,
    "diseaseTerm": "Obesity Due To Sim1 Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:91349",
    "phenodigmScore": 51.135,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011748 Adrenocorticotropic hormone deficiency,HP:0008245 Pituitary hypothyroidism,HP:0008240 Secondary growth hormone deficiency,HP:0012503 Abnormality of the pituitary gland,HP:0000837 Increased circulating gonadotropin level,HP:0000871 Panhypopituitarism,HP:0040075 Hypopituitarism,HP:0000830 Anterior hypopituitarism,HP:0000863 Central diabetes insipidus,HP:0000824 Decreased response to growth hormone stimulation test,HP:0002615 Hypotension,HP:0008202 Reduced circulating prolactin concentration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.8,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.47,
    "markerNumModels": 9,
    "diseaseTerm": "Non-Functioning Pituitary Adenoma",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618213",
    "phenodigmScore": 47.195,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001931 Hypochromic anemia,HP:0002059 Cerebral atrophy,HP:0002079 Hypoplasia of the corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 15.15,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 79.24,
    "markerNumModels": 9,
    "diseaseTerm": "Inflammatory Bowel Disease, Immunodeficiency, And Encephalopathy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:83317",
    "phenodigmScore": 48.83,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.47,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.19,
    "markerNumModels": 9,
    "diseaseTerm": "Scrub Typhus",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2070",
    "phenodigmScore": 49.224999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011227 Elevated circulating C-reactive protein concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.32,
    "diseaseModelAvgRaw": 0.35,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.13,
    "markerNumModels": 9,
    "diseaseTerm": "Eosinophilic Gastroenteritis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:778",
    "phenodigmScore": 46.405,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0000253 Progressive microcephaly,HP:0011451 Primary microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.59,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 78.22,
    "markerNumModels": 9,
    "diseaseTerm": "Rett Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:548",
    "phenodigmScore": 39.525,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000421 Epistaxis,HP:0010827 Abnormality of the seventh cranial nerve,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.19,
    "diseaseModelAvgRaw": 0.15,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 71.86,
    "markerNumModels": 9,
    "diseaseTerm": "Leprosy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:314652",
    "phenodigmScore": 51.78,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012664 Reduced ejection fraction,HP:0002176 Spinal cord compression,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.87,
    "diseaseModelAvgRaw": 0.34,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 86.69,
    "markerNumModels": 9,
    "diseaseTerm": "Variant Abeta2M Amyloidosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617609",
    "phenodigmScore": 61.375,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 31.21,
    "diseaseModelAvgRaw": 0.75,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 15",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:218670",
    "phenodigmScore": 55.445,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002139 Arrhinencephaly,HP:0000609 Optic nerve hypoplasia,HP:0001331 Absent septum pellucidum,HP:0001339 Lissencephaly,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 39.06,
    "diseaseModelAvgRaw": 0.88,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 71.83,
    "markerNumModels": 9,
    "diseaseTerm": "Craniotelencephalic Dysplasia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615486",
    "phenodigmScore": 47.47,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001903 Anemia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 8.17,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 86.77,
    "markerNumModels": 9,
    "diseaseTerm": "Interstitial Lung And Liver Disease",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:442",
    "phenodigmScore": 51.83,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0000822 Hypertension,HP:0000830 Anterior hypopituitarism,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.02,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 90.64,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Hypothyroidism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:276300",
    "phenodigmScore": 44.535,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.6,
    "diseaseModelAvgRaw": 0.47,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 69.47,
    "markerNumModels": 9,
    "diseaseTerm": "Mismatch Repair Cancer Syndrome 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:255700",
    "phenodigmScore": 52.525000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0003730 EMG: myotonic runs,HP:0010548 Percussion myotonia,HP:0003740 Myotonia with warm-up phenomenon",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 27.54,
    "diseaseModelAvgRaw": 0.64,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonia Congenita, Autosomal Recessive",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:207950",
    "phenodigmScore": 56.885,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002475 Myelomeningocele,HP:0003396 Syringomyelia,HP:0002318 Cervical myelopathy,HP:0002414 Spina bifida,HP:0002282 Gray matter heterotopia,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 37.42,
    "diseaseModelAvgRaw": 0.84,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 76.35,
    "markerNumModels": 9,
    "diseaseTerm": "Chiari Malformation Type Ii",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:155950",
    "phenodigmScore": 53.475,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0100774 Hyperostosis,HP:0011001 Increased bone mineral density",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 37.42,
    "diseaseModelAvgRaw": 1.01,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0000063 decreased bone mineral density,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 1.99,
    "diseaseModelMaxNorm": 69.53,
    "markerNumModels": 9,
    "diseaseTerm": "Melorheostosis, Isolated",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:600348",
    "phenodigmScore": 69.4,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0032409 Subcortical band heterotopia,HP:0002126 Polymicrogyria,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 45.1,
    "diseaseModelAvgRaw": 0.94,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 93.7,
    "markerNumModels": 9,
    "diseaseTerm": "Band Heterotopia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:619155",
    "phenodigmScore": 55.629999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 22.54,
    "diseaseModelAvgRaw": 0.55,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 88.72,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 22",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:66529",
    "phenodigmScore": 53.5,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001279 Syncope,HP:0000822 Hypertension,HP:0001657 Prolonged QT interval,HP:0025077 Decreased QRS voltage,HP:0004308 Ventricular arrhythmia,HP:0001653 Mitral regurgitation,HP:0012663 Mildly reduced ejection fraction,HP:0012250 ST segment depression,HP:0001962 Palpitations,HP:0009805 Low-output congestive heart failure,HP:0005184 Prolonged QTc interval,HP:0001681 Angina pectoris,HP:0005110 Atrial fibrillation,HP:0030149 Cardiogenic shock,HP:0001662 Bradycardia,HP:0011675 Arrhythmia,HP:0012251 ST segment elevation,HP:0002615 Hypotension,HP:0001663 Ventricular fibrillation,HP:0010872 T-wave inversion",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 27.76,
    "diseaseModelAvgRaw": 0.67,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 79.24,
    "markerNumModels": 9,
    "diseaseTerm": "Tako-Tsubo Cardiomyopathy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:70587",
    "phenodigmScore": 51.324999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001695 Cardiac arrest,HP:0001649 Tachycardia,HP:0001662 Bradycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 13.6,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.05,
    "markerNumModels": 9,
    "diseaseTerm": "Infant Acute Respiratory Distress Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:79319",
    "phenodigmScore": 49.239999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 13.1,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 85.38,
    "markerNumModels": 9,
    "diseaseTerm": "Mpi-Cdg",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617008",
    "phenodigmScore": 50.635,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.99,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 81.28,
    "markerNumModels": 9,
    "diseaseTerm": "Cerebral Palsy, Spastic Quadriplegic, 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:133020",
    "phenodigmScore": 47.91,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001962 Palpitations,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 14.21,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 81.61,
    "markerNumModels": 9,
    "diseaseTerm": "Erythermalgia, Primary",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614499",
    "phenodigmScore": 75.345,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001302 Pachygyria,HP:0001339 Lissencephaly,HP:0001355 Megalencephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 50.69,
    "diseaseModelAvgRaw": 0.9,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Intellectual Developmental Disorder, Autosomal Recessive 34, With Variant Lissencephaly",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:70578",
    "phenodigmScore": 50.31,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0002633 Vasculitis,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.57,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.05,
    "markerNumModels": 9,
    "diseaseTerm": "Adult Acute Respiratory Distress Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:800",
    "phenodigmScore": 42.44,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0003044 Shoulder flexion contracture,HP:0005830 Flexion contracture of toe,HP:0003273 Hip contracture,HP:0002092 Pulmonary arterial hypertension,HP:0000939 Osteoporosis,HP:0002804 Arthrogryposis multiplex congenita,HP:0001239 Wrist flexion contracture,HP:0011001 Increased bone mineral density,HP:0001387 Joint stiffness,HP:0100569 Abnormally ossified vertebrae,HP:0011675 Arrhythmia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 11.21,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 73.67,
    "markerNumModels": 9,
    "diseaseTerm": "Schwartz-Jampel Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:647",
    "phenodigmScore": 40.415,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.08,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 72.75,
    "markerNumModels": 9,
    "diseaseTerm": "Nijmegen Breakage Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618476",
    "phenodigmScore": 51.085,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0007165 Periventricular heterotopia,HP:0002500 Abnormal cerebral white matter morphology,HP:0002518 Abnormal periventricular white matter morphology,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 26.94,
    "diseaseModelAvgRaw": 0.56,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 75.23,
    "markerNumModels": 9,
    "diseaseTerm": "Brain Abnormalities, Neurodegeneration, And Dysosteosclerosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2063",
    "phenodigmScore": 43.155,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.39,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 79.92,
    "markerNumModels": 9,
    "diseaseTerm": "Splenogonadal Fusion-Limb Defects-Micrognathia Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614748",
    "phenodigmScore": 39.305,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 9.26,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 69.35,
    "markerNumModels": 9,
    "diseaseTerm": "Interstitial Lung Disease, Nephrotic Syndrome, And Epidermolysis Bullosa, Congenital",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618820",
    "phenodigmScore": 44.14,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0006989 Dysplastic corpus callosum,HP:0030048 Colpocephaly,HP:0001331 Absent septum pellucidum,HP:0002126 Polymicrogyria,HP:0002282 Gray matter heterotopia,HP:0005484 Secondary microcephaly,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.76,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 69.52,
    "markerNumModels": 9,
    "diseaseTerm": "Genitourinary And/Or Brain Malformation Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617935",
    "phenodigmScore": 63.735,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 36.18,
    "diseaseModelAvgRaw": 0.77,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Epilepsy, Familial Focal, With Variable Foci 4",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:93256",
    "phenodigmScore": 51.75,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0002615 Hypotension,HP:0002120 Cerebral cortical atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.92,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.58,
    "markerNumModels": 9,
    "diseaseTerm": "Fragile X-Associated Tremor/Ataxia Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615411",
    "phenodigmScore": 76.08500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0032409 Subcortical band heterotopia,HP:0001339 Lissencephaly,HP:0001302 Pachygyria,HP:0031882 Agyria,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0002539 Cortical dysplasia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 52.17,
    "diseaseModelAvgRaw": 0.99,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Cortical Dysplasia, Complex, With Other Brain Malformations 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:89844",
    "phenodigmScore": 56.52,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0045028 Microlissencephaly,HP:0011451 Primary microcephaly,HP:0006818 4-layered lissencephaly,HP:0002514 Cerebral calcification,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 28.14,
    "diseaseModelAvgRaw": 0.57,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 84.9,
    "markerNumModels": 9,
    "diseaseTerm": "Lissencephaly Syndrome, Norman-Roberts Type",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:505248",
    "phenodigmScore": 44.699999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0007703 Abnormality of retinal pigmentation,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 7.77,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 81.63,
    "markerNumModels": 9,
    "diseaseTerm": "Mucopolysaccharidosis-Like Syndrome With Congenital Heart Defects And Hematopoietic Disorders",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:95459",
    "phenodigmScore": 51.824999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010446 Tricuspid stenosis,HP:0002092 Pulmonary arterial hypertension,HP:0005180 Tricuspid regurgitation,HP:0001635 Congestive heart failure,HP:0002615 Hypotension,HP:0030148 Heart murmur",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.16,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.49,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Tricuspid Stenosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:707",
    "phenodigmScore": 40.92,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011675 Arrhythmia,HP:0002248 Hematemesis,HP:0001649 Tachycardia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.4,
    "diseaseModelAvgRaw": 0.14,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 75.44,
    "markerNumModels": 9,
    "diseaseTerm": "Plague",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:84090",
    "phenodigmScore": 54.665,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 20.84,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 88.49,
    "markerNumModels": 9,
    "diseaseTerm": "Fibronectin Glomerulopathy",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:270400",
    "phenodigmScore": 38.925000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007333 Hypoplasia of the frontal lobes,HP:0002251 Aganglionic megacolon,HP:0007165 Periventricular heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.59,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 70.26,
    "markerNumModels": 9,
    "diseaseTerm": "Smith-Lemli-Opitz Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1116",
    "phenodigmScore": 60.355000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003075 Hypoproteinemia,HP:0000567 Chorioretinal coloboma",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 29.59,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 91.12,
    "markerNumModels": 9,
    "diseaseTerm": "Aplasia Cutis Congenita-Intestinal Lymphangiectasia Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:192",
    "phenodigmScore": 45.18000000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000648 Optic atrophy,HP:0000252 Microcephaly,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.21,
    "diseaseModelAvgRaw": 0.19,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 81.15,
    "markerNumModels": 9,
    "diseaseTerm": "Coffin-Lowry Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99734",
    "phenodigmScore": 48.379999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012903 Myotonia of the upper limb,HP:0012899 Handgrip myotonia,HP:0012902 Myotonia of the lower limb,HP:0012900 Myotonia of the face,HP:0003740 Myotonia with warm-up phenomenon",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 23.46,
    "diseaseModelAvgRaw": 0.52,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004084 abnormal cardiac muscle relaxation",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.18,
    "diseaseModelMaxNorm": 73.3,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonia Fluctuans",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:276244",
    "phenodigmScore": 44.66,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0040140 Degeneration of the striatum,HP:0002503 Spinocerebellar tract degeneration,HP:0002366 Abnormal lower motor neuron morphology,HP:0011960 Substantia nigra gliosis,HP:0002398 Degeneration of anterior horn cells",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.44,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.17,
    "diseaseModelMaxNorm": 71.88,
    "markerNumModels": 9,
    "diseaseTerm": "Machado-Joseph Disease Type 3",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:75565",
    "phenodigmScore": 38.059999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 5.66,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 70.46,
    "markerNumModels": 9,
    "diseaseTerm": "Tropical Endomyocardial Fibrosis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614498",
    "phenodigmScore": 56.105000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0001662 Bradycardia,HP:0000253 Progressive microcephaly,HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.92,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 91.29,
    "markerNumModels": 9,
    "diseaseTerm": "Rigidity And Multifocal Seizure Syndrome, Lethal Neonatal",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:171703",
    "phenodigmScore": 63.040000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002126 Polymicrogyria,HP:0001274 Agenesis of corpus callosum,HP:0011451 Primary microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 42.71,
    "diseaseModelAvgRaw": 0.9,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.04,
    "diseaseModelMaxNorm": 83.37,
    "markerNumModels": 9,
    "diseaseTerm": "Microcephaly-Polymicrogyria-Corpus Callosum Agenesis Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3260",
    "phenodigmScore": 53.06,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0002170 Intracranial hemorrhage,HP:0001903 Anemia,HP:0200029 Vasculitis in the skin,HP:0030880 Raynaud phenomenon,HP:0001744 Splenomegaly,HP:0005547 Myeloproliferative disorder,HP:0001433 Hepatosplenomegaly,HP:0002326 Transient ischemic attack,HP:0011897 Neutrophilia,HP:0002204 Pulmonary embolism,HP:0001635 Congestive heart failure,HP:0001873 Thrombocytopenia,HP:0001880 Eosinophilia,HP:0005115 Supraventricular arrhythmia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 17.48,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009937 abnormal neuron differentiation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 88.64,
    "markerNumModels": 9,
    "diseaseTerm": "Idiopathic Hypereosinophilic Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2671",
    "phenodigmScore": 48.06,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002536 Abnormal cortical gyration,HP:0002269 Abnormality of neuronal migration,HP:0001331 Absent septum pellucidum,HP:0001302 Pachygyria,HP:0007227 Macrogyria,HP:0002414 Spina bifida,HP:0002126 Polymicrogyria,HP:0002514 Cerebral calcification,HP:0001339 Lissencephaly,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.25,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 77.87,
    "markerNumModels": 9,
    "diseaseTerm": "Neu-Laxova Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3318",
    "phenodigmScore": 56.345,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001658 Myocardial infarction,HP:0011974 Myelofibrosis,HP:0002326 Transient ischemic attack",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 33.39,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Essential Thrombocythemia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:605750",
    "phenodigmScore": 60.88,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0008052 Retinal fold,HP:0030490 Exudative vitreoretinopathy,HP:0011530 Retinal hole,HP:0001147 Retinal exudate,HP:0000541 Retinal detachment",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 47.5,
    "diseaseModelAvgRaw": 1.02,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.01,
    "diseaseModelMaxNorm": 74.26,
    "markerNumModels": 9,
    "diseaseTerm": "Exudative Vitreoretinopathy 3",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:556030",
    "phenodigmScore": 51.485,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.35,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 87.62,
    "markerNumModels": 9,
    "diseaseTerm": "Early-Onset Familial Hypoaldosteronism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:454836",
    "phenodigmScore": 46.865,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003236 Elevated circulating creatine kinase concentration,HP:0011227 Elevated circulating C-reactive protein concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.26,
    "diseaseModelAvgRaw": 0.23,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.47,
    "markerNumModels": 9,
    "diseaseTerm": "Avian Influenza",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:682",
    "phenodigmScore": 46.185,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0011675 Arrhythmia,HP:0001635 Congestive heart failure,HP:0001371 Flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 17.0,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 75.37,
    "markerNumModels": 9,
    "diseaseTerm": "Hyperkalemic Periodic Paralysis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:261740",
    "phenodigmScore": 48.58,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001662 Bradycardia,HP:0001638 Cardiomyopathy,HP:0001635 Congestive heart failure,HP:0005165 Shortened PR interval,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.92,
    "diseaseModelAvgRaw": 0.38,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.24,
    "markerNumModels": 9,
    "diseaseTerm": "Glycogen Storage Disease Of Heart, Lethal Congenital",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618347",
    "phenodigmScore": 52.470000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 13.4,
    "diseaseModelAvgRaw": 0.28,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Galloway-Mowat Syndrome 6",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1083",
    "phenodigmScore": 72.25999999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007165 Periventricular heterotopia,HP:0007190 Neuronal loss in the cerebral cortex,HP:0009879 Simplified gyral pattern,HP:0001339 Lissencephaly,HP:0001302 Pachygyria,HP:0006891 Thick cerebral cortex,HP:0002079 Hypoplasia of the corpus callosum,HP:0002126 Polymicrogyria,HP:0032391 Subcortical heterotopia,HP:0007266 Cerebral dysmyelination,HP:0002120 Cerebral cortical atrophy,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 49.78,
    "diseaseModelAvgRaw": 0.98,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 94.74,
    "markerNumModels": 9,
    "diseaseTerm": "Microlissencephaly",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:397941",
    "phenodigmScore": 42.87,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007165 Periventricular heterotopia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 4.21,
    "diseaseModelAvgRaw": 0.08,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 81.53,
    "markerNumModels": 9,
    "diseaseTerm": "Man1B1-Cdg",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:91354",
    "phenodigmScore": 58.019999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011748 Adrenocorticotropic hormone deficiency,HP:0008245 Pituitary hypothyroidism,HP:0040075 Hypopituitarism,HP:0000863 Central diabetes insipidus,HP:0000824 Decreased response to growth hormone stimulation test,HP:0002615 Hypotension,HP:0000870 Increased circulating prolactin concentration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 23.65,
    "diseaseModelAvgRaw": 0.56,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 92.39,
    "markerNumModels": 9,
    "diseaseTerm": "Pituitary Deficiency Due To Empty Sella Turcica Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:729",
    "phenodigmScore": 54.004999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0002639 Budd-Chiari syndrome,HP:0000421 Epistaxis,HP:0011974 Myelofibrosis,HP:0004417 Intermittent claudication,HP:0002239 Gastrointestinal hemorrhage,HP:0002204 Pulmonary embolism,HP:0001409 Portal hypertension,HP:0001681 Angina pectoris",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 28.71,
    "diseaseModelAvgRaw": 0.65,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Polycythemia Vera",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615558",
    "phenodigmScore": 53.834999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003563 Decreased LDL cholesterol concentration,HP:0000546 Retinal degeneration,HP:0000510 Rod-cone dystrophy",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 42.54,
    "diseaseModelAvgRaw": 0.97,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.01,
    "diseaseModelMaxNorm": 65.13,
    "markerNumModels": 9,
    "diseaseTerm": "Hypobetalipoproteinemia, Familial, 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:156310",
    "phenodigmScore": 61.87,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002270 Abnormality of the autonomic nervous system,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.05,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 98.69,
    "markerNumModels": 9,
    "diseaseTerm": "Metachromatic Leukodystrophy, Adult-Onset, With Normal Arylsulfatase A",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616683",
    "phenodigmScore": 51.165000000000006,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0005484 Secondary microcephaly,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 21.07,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 81.26,
    "markerNumModels": 9,
    "diseaseTerm": "Leukodystrophy, Hypomyelinating, 12",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618797",
    "phenodigmScore": 46.385000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0002059 Cerebral atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.48,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 77.29,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder With Hypotonia, Neonatal Respiratory Insufficiency, And Thermodysregulation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:90041",
    "phenodigmScore": 57.585,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002152 Hyperproteinemia,HP:0002149 Hyperuricemia,HP:0003124 Hypercholesterolemia,HP:0002155 Hypertriglyceridemia,HP:0000848 Increased circulating renin level",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 15.17,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 3.34,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Gaisb√∂ck Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:7",
    "phenodigmScore": 44.805,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000648 Optic atrophy,HP:0001650 Aortic valve stenosis,HP:0001642 Pulmonic stenosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 6.15,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 83.46,
    "markerNumModels": 9,
    "diseaseTerm": "3C Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:275761",
    "phenodigmScore": 43.54,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011106 Hypovolemia,HP:0002092 Pulmonary arterial hypertension,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 5.28,
    "diseaseModelAvgRaw": 0.13,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 81.8,
    "markerNumModels": 9,
    "diseaseTerm": "Lysosomal Acid Lipase Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:88643",
    "phenodigmScore": 59.215,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 26.89,
    "diseaseModelAvgRaw": 0.67,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Obesity-Colitis-Hypothyroidism-Cardiac Hypertrophy-Developmental Delay Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:542323",
    "phenodigmScore": 50.345,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012664 Reduced ejection fraction,HP:0001649 Tachycardia,HP:0012722 Heart block,HP:0011675 Arrhythmia,HP:0002615 Hypotension,HP:0030005 Capillary leak",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.64,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 89.05,
    "markerNumModels": 9,
    "diseaseTerm": "Car T Cell Therapy-Associated Cytokine Release Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:614441",
    "phenodigmScore": 49.795,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 20.31,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 79.28,
    "markerNumModels": 9,
    "diseaseTerm": "Hypertrophic Osteoarthropathy, Primary, Autosomal Recessive, 2",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:35069",
    "phenodigmScore": 50.145,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0012677 Iron accumulation in globus pallidus,HP:0002500 Abnormal cerebral white matter morphology,HP:0003134 Abnormality of peripheral nerve conduction,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.26,
    "diseaseModelAvgRaw": 0.31,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 85.03,
    "markerNumModels": 9,
    "diseaseTerm": "Infantile Neuroaxonal Dystrophy",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:246700",
    "phenodigmScore": 57.614999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003146 Hypocholesterolemia,HP:0012153 Hypotriglyceridemia,HP:0003563 Decreased LDL cholesterol concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 31.4,
    "diseaseModelAvgRaw": 0.66,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.83,
    "markerNumModels": 9,
    "diseaseTerm": "Chylomicron Retention Disease",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:36238",
    "phenodigmScore": 47.895,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.25,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 88.54,
    "markerNumModels": 9,
    "diseaseTerm": "Staphylococcal Necrotizing Pneumonia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1980",
    "phenodigmScore": 62.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly,HP:0002514 Cerebral calcification",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 28.32,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 96.71,
    "markerNumModels": 9,
    "diseaseTerm": "Bilateral Striopallidodentate Calcinosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:324636",
    "phenodigmScore": 54.94,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0002170 Intracranial hemorrhage,HP:0008352 Impaired platelet adhesion,HP:0005261 Joint hemorrhage,HP:0000421 Epistaxis,HP:0002239 Gastrointestinal hemorrhage,HP:0001973 Autoimmune thrombocytopenia,HP:0001877 Abnormal erythrocyte morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 18.89,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 90.99,
    "markerNumModels": 9,
    "diseaseTerm": "Autoerythrocyte Sensitization Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:611637",
    "phenodigmScore": 54.01,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002127 Abnormal upper motor neuron morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.99,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 90.03,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Lateral Sclerosis, Adult, 1",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:744",
    "phenodigmScore": 36.095,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001645 Sudden cardiac death,HP:0002282 Gray matter heterotopia,HP:0002204 Pulmonary embolism",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 3.41,
    "diseaseModelAvgRaw": 0.07,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 68.78,
    "markerNumModels": 9,
    "diseaseTerm": "Proteus Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2149",
    "phenodigmScore": 59.18,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 18.36,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Nodular Neuronal Heterotopia",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:475",
    "phenodigmScore": 48.065,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0007370 Aplasia/Hypoplasia of the corpus callosum,HP:0002251 Aganglionic megacolon,HP:0002126 Polymicrogyria",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.22,
    "diseaseModelAvgRaw": 0.36,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 78.91,
    "markerNumModels": 9,
    "diseaseTerm": "Joubert Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:35689",
    "phenodigmScore": 45.93,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010873 Cervical spinal cord atrophy,HP:0002127 Abnormal upper motor neuron morphology,HP:0006827 Atrophy of the spinal cord",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.66,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 72.2,
    "markerNumModels": 9,
    "diseaseTerm": "Primary Lateral Sclerosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:263400",
    "phenodigmScore": 51.32,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001342 Cerebral hemorrhage,HP:0001898 Increased red blood cell mass,HP:0001899 Increased hematocrit,HP:0002615 Hypotension,HP:0001900 Increased hemoglobin",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 30.52,
    "diseaseModelAvgRaw": 0.76,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.21,
    "diseaseModelMaxNorm": 72.12,
    "markerNumModels": 9,
    "diseaseTerm": "Erythrocytosis, Familial, 2",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:226300",
    "phenodigmScore": 55.97,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001891 Iron deficiency anemia,HP:0001894 Thrombocytosis,HP:0002204 Pulmonary embolism,HP:0002639 Budd-Chiari syndrome",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 20.1,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 91.84,
    "markerNumModels": 9,
    "diseaseTerm": "Complement Hyperactivation, Angiopathic Thrombosis, And Protein-Losing Enteropathy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:98933",
    "phenodigmScore": 51.709999999999994,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0012670 Orthostatic syncope,HP:0030880 Raynaud phenomenon,HP:0005341 Autonomic bladder dysfunction,HP:0008652 Autonomic erectile dysfunction,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.96,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 82.46,
    "markerNumModels": 9,
    "diseaseTerm": "Multiple System Atrophy, Parkinsonian Type",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:261552",
    "phenodigmScore": 37.475,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0040331 Focal hypointensity of cerebral white matter on MRI,HP:0000648 Optic atrophy,HP:0002251 Aganglionic megacolon,HP:0012430 Cerebral white matter hypoplasia,HP:0007048 Large basal ganglia,HP:0007165 Periventricular heterotopia,HP:0001273 Abnormal corpus callosum morphology,HP:0011451 Primary microcephaly,HP:0001642 Pulmonic stenosis,HP:0002126 Polymicrogyria,HP:0030303 Hypoplastic anterior commissure,HP:0001650 Aortic valve stenosis,HP:0006956 Dilation of lateral ventricles,HP:0005484 Secondary microcephaly,HP:0002079 Hypoplasia of the corpus callosum,HP:0025100 Abnormal hippocampus morphology,HP:0001274 Agenesis of corpus callosum,HP:0011886 Hyphema",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.13,
    "diseaseModelAvgRaw": 0.25,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.24,
    "diseaseModelMaxNorm": 63.82,
    "markerNumModels": 9,
    "diseaseTerm": "Mowat-Wilson Syndrome Due To A Zeb2 Point Mutation",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:134",
    "phenodigmScore": 54.935,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001974 Leukocytosis,HP:0002615 Hypotension,HP:0001894 Thrombocytosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 17.87,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 92.0,
    "markerNumModels": 9,
    "diseaseTerm": "Beta-Ketothiolase Deficiency",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:212750",
    "phenodigmScore": 50.754999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001891 Iron deficiency anemia,HP:0001894 Thrombocytosis,HP:0001972 Macrocytic anemia,HP:0002514 Cerebral calcification",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 9.54,
    "diseaseModelAvgRaw": 0.22,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 91.97,
    "markerNumModels": 9,
    "diseaseTerm": "Celiac Disease, Susceptibility To, 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:209950",
    "phenodigmScore": 56.825,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0001903 Anemia,HP:0001744 Splenomegaly,HP:0001433 Hepatosplenomegaly,HP:0100727 Histiocytosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 13.65,
    "diseaseModelAvgRaw": 0.3,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 100.0,
    "markerNumModels": 9,
    "diseaseTerm": "Immunodeficiency 27A",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:75564",
    "phenodigmScore": 65.60499999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001894 Thrombocytosis,HP:0001875 Neutropenia,HP:0001897 Normocytic anemia,HP:0200143 Megaloblastic erythroid hyperplasia,HP:0012132 Erythroid hyperplasia,HP:0001895 Normochromic anemia,HP:0011447 Hyposegmentation of neutrophil nuclei,HP:0001931 Hypochromic anemia,HP:0001744 Splenomegaly,HP:0004808 Acute myeloid leukemia,HP:0001635 Congestive heart failure,HP:0001876 Pancytopenia,HP:0001873 Thrombocytopenia,HP:0001913 Granulocytopenia,HP:0010972 Anemia of inadequate production",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 33.97,
    "diseaseModelAvgRaw": 0.74,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 97.24,
    "markerNumModels": 9,
    "diseaseTerm": "Acquired Idiopathic Sideroblastic Anemia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:167",
    "phenodigmScore": 49.135,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0007703 Abnormality of retinal pigmentation,HP:0003075 Hypoproteinemia,HP:0001337 Tremor,HP:0003281 Increased circulating ferritin concentration,HP:0002155 Hypertriglyceridemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 10.95,
    "diseaseModelAvgRaw": 0.24,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0001513 limb grasping,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.72,
    "diseaseModelMaxNorm": 87.32,
    "markerNumModels": 9,
    "diseaseTerm": "Ch√©diak-Higashi Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2772",
    "phenodigmScore": 50.765,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 15.09,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 86.44,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Osteogenesis Imperfecta-Microcephaly-Cataracts Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:160",
    "phenodigmScore": 47.144999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001723 Restrictive cardiomyopathy,HP:0011974 Myelofibrosis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 17.65,
    "diseaseModelAvgRaw": 0.39,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 76.64,
    "markerNumModels": 9,
    "diseaseTerm": "Castleman Disease",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:391307",
    "phenodigmScore": 46.615,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0001888 Lymphopenia,HP:0002500 Abnormal cerebral white matter morphology,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 15.72,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0009969 abnormal cerebral cortex pyramidal cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Severe Intellectual Disability-Short Stature-Behavioral Abnormalities-Facial Dysmorphism Syndrome",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:618183",
    "phenodigmScore": 47.135,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0003073 Hypoalbuminemia,HP:0002917 Hypomagnesemia,HP:0002155 Hypertriglyceridemia,HP:0002901 Hypocalcemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 18.11,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 76.16,
    "markerNumModels": 9,
    "diseaseTerm": "Diarrhea 10, Protein-Losing Enteropathy Type",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:255249",
    "phenodigmScore": 46.775,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 11.89,
    "diseaseModelAvgRaw": 0.27,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 81.66,
    "markerNumModels": 9,
    "diseaseTerm": "Leigh Syndrome With Nephrotic Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:1667",
    "phenodigmScore": 46.83,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002902 Hyponatremia,HP:0003073 Hypoalbuminemia,HP:0002904 Hyperbilirubinemia,HP:0001987 Hyperammonemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 11.53,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 82.13,
    "markerNumModels": 9,
    "diseaseTerm": "Wolcott-Rallison Syndrome",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99825",
    "phenodigmScore": 51.839999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 10.63,
    "diseaseModelAvgRaw": 0.21,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 93.05,
    "markerNumModels": 9,
    "diseaseTerm": "Nipah Virus Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:85451",
    "phenodigmScore": 52.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001639 Hypertrophic cardiomyopathy,HP:0012664 Reduced ejection fraction,HP:0001681 Angina pectoris,HP:0001723 Restrictive cardiomyopathy,HP:0005150 Abnormal atrioventricular conduction,HP:0001635 Congestive heart failure,HP:0025028 Abnormality of enteric nervous system morphology,HP:0003115 Abnormal EKG,HP:0001650 Aortic valve stenosis,HP:0011675 Arrhythmia,HP:0001692 Atrial arrhythmia,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.63,
    "diseaseModelAvgRaw": 0.59,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 79.4,
    "markerNumModels": 9,
    "diseaseTerm": "Attrv122I Amyloidosis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:100076",
    "phenodigmScore": 48.9,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001708 Right ventricular failure,HP:0010446 Tricuspid stenosis,HP:0001962 Palpitations,HP:0002249 Melena,HP:0001642 Pulmonic stenosis,HP:0030149 Cardiogenic shock,HP:0000845 Elevated circulating growth hormone concentration,HP:0002248 Hematemesis,HP:0011675 Arrhythmia,HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 17.31,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.49,
    "markerNumModels": 9,
    "diseaseTerm": "Duodenal Neuroendocrine Tumor",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:169500",
    "phenodigmScore": 54.58,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0004926 Orthostatic hypotension due to autonomic dysfunction,HP:0006994 Diffuse leukoencephalopathy,HP:0007371 Corpus callosum atrophy,HP:0005341 Autonomic bladder dysfunction,HP:0008652 Autonomic erectile dysfunction",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 29.71,
    "diseaseModelAvgRaw": 0.63,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.35,
    "diseaseModelMaxNorm": 79.45,
    "markerNumModels": 9,
    "diseaseTerm": "Leukodystrophy, Demyelinating, Adult-Onset, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:103910",
    "phenodigmScore": 56.525,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011012 Abnormal circulating polysaccharide concentration,HP:0010876 Abnormal circulating protein concentration,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 29.92,
    "diseaseModelAvgRaw": 0.7,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 83.13,
    "markerNumModels": 9,
    "diseaseTerm": "Congenital Enterocyte Heparan Sulfate Deficiency",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:605543",
    "phenodigmScore": 59.775,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001278 Orthostatic hypotension,HP:0100315 Lewy bodies,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 43.45,
    "diseaseModelAvgRaw": 1.01,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 76.1,
    "markerNumModels": 9,
    "diseaseTerm": "Parkinson Disease 4, Autosomal Dominant",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:251300",
    "phenodigmScore": 44.285000000000004,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 7.29,
    "diseaseModelAvgRaw": 0.16,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 81.28,
    "markerNumModels": 9,
    "diseaseTerm": "Galloway-Mowat Syndrome 1",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2483",
    "phenodigmScore": 44.565000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0010628 Facial palsy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 11.34,
    "diseaseModelAvgRaw": 0.26,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0004184 abnormal baroreceptor physiology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 77.79,
    "markerNumModels": 9,
    "diseaseTerm": "Melkersson-Rosenthal Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616937",
    "phenodigmScore": 59.82,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0011974 Myelofibrosis,HP:0000939 Osteoporosis,HP:0004406 Spontaneous\\, recurrent epistaxis",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 40.34,
    "diseaseModelAvgRaw": 0.96,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Thrombocytopenia 6",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:2518",
    "phenodigmScore": 50.535,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0000648 Optic atrophy,HP:0002120 Cerebral cortical atrophy,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 22.16,
    "diseaseModelAvgRaw": 0.46,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 78.91,
    "markerNumModels": 9,
    "diseaseTerm": "Autosomal Recessive Chorioretinopathy-Microcephaly Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607694",
    "phenodigmScore": 50.205,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0002079 Hypoplasia of the corpus callosum,HP:0002127 Abnormal upper motor neuron morphology,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.72,
    "diseaseModelAvgRaw": 0.43,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0008503 abnormal spinal cord grey matter morphology,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 79.69,
    "markerNumModels": 9,
    "diseaseTerm": "Leukodystrophy, Hypomyelinating, 7, With Or Without Oligodontia And/Or Hypogonadotropic Hypogonadism",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:58",
    "phenodigmScore": 52.39,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000822 Hypertension,HP:0001355 Megalencephaly,HP:0010628 Facial palsy,HP:0002514 Cerebral calcification,HP:0001645 Sudden cardiac death,HP:0002615 Hypotension,HP:0001274 Agenesis of corpus callosum,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 19.64,
    "diseaseModelAvgRaw": 0.42,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 85.14,
    "markerNumModels": 9,
    "diseaseTerm": "Alexander Disease",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:99826",
    "phenodigmScore": 43.94,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0031273 Shock,HP:0001701 Pericarditis,HP:0011896 Subconjunctival hemorrhage,HP:0001649 Tachycardia,HP:0001662 Bradycardia,HP:0011106 Hypovolemia,HP:0011029 Internal hemorrhage,HP:0002615 Hypotension,HP:0030005 Capillary leak",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.82,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 80.06,
    "markerNumModels": 9,
    "diseaseTerm": "Marburg Hemorrhagic Fever",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:83601",
    "phenodigmScore": 52.76,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012332 Abnormal autonomic nervous system physiology,HP:0005318 Cerebral vasculitis,HP:0002500 Abnormal cerebral white matter morphology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 20.13,
    "diseaseModelAvgRaw": 0.45,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0001596 hypotension,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 85.39,
    "markerNumModels": 9,
    "diseaseTerm": "Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:208920",
    "phenodigmScore": 53.06,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001337 Tremor,HP:0003124 Hypercholesterolemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 17.29,
    "diseaseModelAvgRaw": 0.37,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001513 limb grasping,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 88.83,
    "markerNumModels": 9,
    "diseaseTerm": "Ataxia, Early-Onset, With Oculomotor Apraxia And Hypoalbuminemia",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615934",
    "phenodigmScore": 56.78,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001009 Telangiectasia,HP:0001894 Thrombocytosis,HP:0001882 Leukopenia,HP:0001903 Anemia,HP:0030880 Raynaud phenomenon,HP:0001888 Lymphopenia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 18.39,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 95.17,
    "markerNumModels": 9,
    "diseaseTerm": "Sting-Associated Vasculopathy, Infantile-Onset",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:160900",
    "phenodigmScore": 49.7,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002486 Myotonia,HP:0005110 Atrial fibrillation,HP:0004749 Atrial flutter,HP:0002059 Cerebral atrophy,HP:0011705 First degree atrioventricular block",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 21.89,
    "diseaseModelAvgRaw": 0.48,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0003822 decreased left ventricle systolic pressure,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Myotonic Dystrophy 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:3385",
    "phenodigmScore": 46.265,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0012819 Myocarditis,HP:0040086 Abnormal prolactin level,HP:0001709 Third degree atrioventricular block,HP:0001701 Pericarditis,HP:0030050 Narcolepsy,HP:0001744 Splenomegaly,HP:0011706 Second degree atrioventricular block,HP:0001433 Hepatosplenomegaly,HP:0001635 Congestive heart failure,HP:0002500 Abnormal cerebral white matter morphology,HP:0003115 Abnormal EKG,HP:0012751 Abnormal basal ganglia MRI signal intensity,HP:0011675 Arrhythmia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 14.61,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0001501 abnormal sleep pattern,MP:0009969 abnormal cerebral cortex pyramidal cell morphology,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.65,
    "diseaseModelMaxNorm": 77.92,
    "markerNumModels": 9,
    "diseaseTerm": "African Trypanosomiasis",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:352665",
    "phenodigmScore": 41.315,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000609 Optic nerve hypoplasia,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0001274 Agenesis of corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 8.91,
    "diseaseModelAvgRaw": 0.2,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 73.72,
    "markerNumModels": 9,
    "diseaseTerm": "Neurodevelopmental Disorder-Craniofacial Dysmorphism-Cardiac Defect-Skeletal Anomalies Syndrome Due To 9Q21.3 Microdeletion",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:612289",
    "phenodigmScore": 39.275,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0007165 Periventricular heterotopia,HP:0002092 Pulmonary arterial hypertension,HP:0005180 Tricuspid regurgitation,HP:0002282 Gray matter heterotopia,HP:0002079 Hypoplasia of the corpus callosum,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 7.47,
    "diseaseModelAvgRaw": 0.17,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 71.08,
    "markerNumModels": 9,
    "diseaseTerm": "Fontaine Progeroid Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:600995",
    "phenodigmScore": 61.010000000000005,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003077 Hyperlipidemia,HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 30.48,
    "diseaseModelAvgRaw": 0.72,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Nephrotic Syndrome, Type 2",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:509",
    "phenodigmScore": 55.925,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002152 Hyperproteinemia,HP:0012424 Chorioretinitis,HP:0100653 Optic neuritis,HP:0001085 Papilledema,HP:0030497 Macular cotton wool spot,HP:0000573 Retinal hemorrhage",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 18.38,
    "diseaseModelAvgRaw": 0.41,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001325 abnormal retina morphology,MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 3.34,
    "diseaseModelMaxNorm": 93.47,
    "markerNumModels": 9,
    "diseaseTerm": "Leptospirosis",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:447896",
    "phenodigmScore": 49.82,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0000648 Optic atrophy,HP:0005341 Autonomic bladder dysfunction,HP:0002134 Abnormality of the basal ganglia,HP:0002079 Hypoplasia of the corpus callosum,HP:0002120 Cerebral cortical atrophy",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 16.23,
    "diseaseModelAvgRaw": 0.33,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.35,
    "diseaseModelMaxNorm": 83.41,
    "markerNumModels": 9,
    "diseaseTerm": "Tremor-Ataxia-Central Hypomyelination Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617397",
    "phenodigmScore": 51.739999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001342 Cerebral hemorrhage,HP:0001662 Bradycardia,HP:0002126 Polymicrogyria,HP:0002514 Cerebral calcification,HP:0002282 Gray matter heterotopia,HP:0000252 Microcephaly",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.54,
    "diseaseModelAvgRaw": 0.58,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.3,
    "diseaseModelMaxNorm": 77.94,
    "markerNumModels": 9,
    "diseaseTerm": "Pseudo-Torch Syndrome 2",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:615668",
    "phenodigmScore": 53.515,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002615 Hypotension",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 9.34,
    "diseaseModelAvgRaw": 0.18,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0001596 hypotension",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.64,
    "diseaseModelMaxNorm": 97.69,
    "markerNumModels": 9,
    "diseaseTerm": "Chromosome 5Q12 Deletion Syndrome",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:261",
    "phenodigmScore": 48.30500000000001,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001644 Dilated cardiomyopathy,HP:0001639 Hypertrophic cardiomyopathy,HP:0002486 Myotonia,HP:0005155 Ventricular escape rhythm,HP:0001678 Atrioventricular block,HP:0001771 Achilles tendon contracture,HP:0004631 Decreased cervical spine flexion due to contractures of posterior cervical muscles,HP:0001387 Joint stiffness,HP:0001645 Sudden cardiac death,HP:0005115 Supraventricular arrhythmia,HP:0002987 Elbow flexion contracture",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 19.1,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.25,
    "diseaseModelMaxNorm": 77.51,
    "markerNumModels": 9,
    "diseaseTerm": "Emery-Dreifuss Muscular Dystrophy",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:616840",
    "phenodigmScore": 51.754999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002185 Neurofibrillary tangles,HP:0100315 Lewy bodies,HP:0002120 Cerebral cortical atrophy,HP:0012332 Abnormal autonomic nervous system physiology",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 27.41,
    "diseaseModelAvgRaw": 0.62,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0004184 abnormal baroreceptor physiology,MP:0006254 thin cerebral cortex",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.45,
    "diseaseModelMaxNorm": 76.1,
    "markerNumModels": 9,
    "diseaseTerm": "Parkinson Disease 23, Autosomal Recessive Early-Onset",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:617156",
    "phenodigmScore": 54.47,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0003073 Hypoalbuminemia",
    "type": "disease_model_summary",
    "modelSource": "IMPC",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1b(EUCOMM)Wtsi> hom early",
    "diseaseModelAvgNorm": 17.4,
    "diseaseModelAvgRaw": 0.4,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005568 increased circulating total protein level,MP:0002965 increased circulating serum albumin level",
    "modelId": "MGI:5637206#hom#early",
    "diseaseModelMaxRaw": 2.5,
    "diseaseModelMaxNorm": 91.54,
    "markerNumModels": 9,
    "diseaseTerm": "Mitochondrial Dna Depletion Syndrome 15 (Hepatocerebral Type)",
    "modelGeneticBackground": "C57BL/6NTac"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:263300",
    "phenodigmScore": 66.89,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001342 Cerebral hemorrhage,HP:0001894 Thrombocytosis,HP:0001974 Leukocytosis,HP:0001898 Increased red blood cell mass,HP:0002639 Budd-Chiari syndrome,HP:0002637 Cerebral ischemia,HP:0001744 Splenomegaly,HP:0002239 Gastrointestinal hemorrhage,HP:0001899 Increased hematocrit,HP:0001873 Thrombocytopenia,HP:0001900 Increased hemoglobin",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 39.91,
    "diseaseModelAvgRaw": 0.98,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0003824 decreased left ventricle developed pressure,MP:0005505 thrombocytosis,MP:0003026 decreased vasoconstriction,MP:0004084 abnormal cardiac muscle relaxation,MP:0006410 abnormal common myeloid progenitor cell morphology,MP:0003822 decreased left ventricle systolic pressure,MP:0005140 decreased cardiac muscle contractility,MP:0004876 decreased mean systemic arterial blood pressure",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 93.87,
    "markerNumModels": 9,
    "diseaseTerm": "Polycythemia Vera",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:157",
    "phenodigmScore": 50.419999999999995,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0002269 Abnormality of neuronal migration,HP:0001638 Cardiomyopathy,HP:0001302 Pachygyria,HP:0002126 Polymicrogyria,HP:0002514 Cerebral calcification,HP:0002134 Abnormality of the basal ganglia,HP:0011675 Arrhythmia,HP:0001274 Agenesis of corpus callosum",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Zllr>/Fgf2<tm1Zllr>",
    "diseaseModelAvgNorm": 25.52,
    "diseaseModelAvgRaw": 0.54,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003241 loss of cortex neurons,MP:0000788 abnormal cerebral cortex morphology,MP:0009974 decreased cerebral cortex pyramidal cell number,MP:0000790 abnormal stratification in cerebral cortex,MP:0001596 hypotension,MP:0006254 thin cerebral cortex,MP:0008221 abnormal hippocampal commissure morphology,MP:0006009 abnormal neuronal migration",
    "modelId": "MGI:3693850",
    "diseaseModelMaxRaw": 2.36,
    "diseaseModelMaxNorm": 75.32,
    "markerNumModels": 9,
    "diseaseTerm": "Carnitine Palmitoyltransferase Ii Deficiency",
    "modelGeneticBackground": "involves: 129S1/Sv * 129X1/SvJ * C57BL/6J"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "ORPHA:232",
    "phenodigmScore": 57.56999999999999,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001974 Leukocytosis,HP:0001743 Abnormality of the spleen,HP:0001894 Thrombocytosis,HP:0005518 Increased mean corpuscular volume,HP:0001891 Iron deficiency anemia,HP:0001931 Hypochromic anemia,HP:0011904 Persistence of hemoglobin F,HP:0001935 Microcytic anemia,HP:0004870 Chronic hemolytic anemia,HP:0001923 Reticulocytosis,HP:0001878 Hemolytic anemia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 20.4,
    "diseaseModelAvgRaw": 0.49,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 94.74,
    "markerNumModels": 9,
    "diseaseTerm": "Sickle Cell Anemia",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:604416",
    "phenodigmScore": 56.86,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001876 Pancytopenia,HP:0001894 Thrombocytosis,HP:0001433 Hepatosplenomegaly,HP:0001935 Microcytic anemia",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm1Doe>/Fgf2<tm1Doe>",
    "diseaseModelAvgNorm": 14.43,
    "diseaseModelAvgRaw": 0.32,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0005505 thrombocytosis,MP:0006410 abnormal common myeloid progenitor cell morphology",
    "modelId": "MGI:2679603",
    "diseaseModelMaxRaw": 2.81,
    "diseaseModelMaxNorm": 99.29,
    "markerNumModels": 9,
    "diseaseTerm": "Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, And Acne",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  },
  {
    "mgiGeneAccessionId": "MGI:95516",
    "diseaseId": "OMIM:607721",
    "phenodigmScore": 46.464999999999996,
    "associationCurated": false,
    "diseaseMatchedPhenotypes": "HP:0001639 Hypertrophic cardiomyopathy,HP:0001659 Aortic regurgitation,HP:0011974 Myelofibrosis,HP:0001642 Pulmonic stenosis,HP:0001388 Joint laxity",
    "type": "disease_model_summary",
    "modelSource": "MGI",
    "markerSymbol": "Fgf2",
    "modelDescription": "Fgf2<tm2Doe>/Fgf2<tm2Doe>",
    "diseaseModelAvgNorm": 13.63,
    "diseaseModelAvgRaw": 0.29,
    "markerLocus": "3:37402616-37464255",
    "modelMatchedPhenotypes": "MP:0003222 increased cardiomyocyte apoptosis,MP:0000063 decreased bone mineral density,MP:0004084 abnormal cardiac muscle relaxation,MP:0003822 decreased left ventricle systolic pressure,MP:0002397 abnormal bone marrow morphology,MP:0010124 decreased bone mineral content,MP:0005140 decreased cardiac muscle contractility",
    "modelId": "MGI:3513670",
    "diseaseModelMaxRaw": 2.52,
    "diseaseModelMaxNorm": 79.3,
    "markerNumModels": 9,
    "diseaseTerm": "Noonan Syndrome-Like Disorder With Loose Anagen Hair 1",
    "modelGeneticBackground": "involves: 129P2/OlaHsd * Black Swiss"
  }
]